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Abstract
Health inequalities are the unfair and avoidable differences in people’s
health between different social groups. These inequalities have a huge
impact on people’s lives, particularly those who live at the poorer end of
the socio-economic spectrum, as they result in prolonged ill health and
shorter lives. Much of the existing research into health inequalities in
Scotland lacks analysis at the small area scale. The work in this thesis
aims to fill that gap by estimating health inequalities in Scotland over
time at the small area level used for data collection, which are known as
intermediate geographies (IGs), as well as between Scotland’s 14 regional
health boards, which are responsible for the protection and improvement
of their populations’ health. This thesis utilises conditional autoregressive
(CAR) models which are the most common modelling approach for areal
unit data. The first model proposed aims to estimate inequalities in risk
of coronary heart disease from 2003 to 2012 across Scotland. However,
focusing on a single disease gives an incomplete picture of the overall in-
equality in population health. Therefore, the second model proposed is a
novel multivariate spatio-temporal model for quantifying health inequal-
ities in Scotland across multiple diseases, which will enable us to better
understand how these inequalities vary and correlate across diseases and
how they have changed over time. This methodology is applied to hos-
pital admissions data for cerebrovascular disease, coronary heart disease
and respiratory disease, three of the leading causes of death, from 2003 to
2012 across Scotland. Finally, it was identified that a common problem in
areal unit data of this type is changes to boundaries which occur during
the time period for which data are available. This occured in Scotland
when the IG boundaries were redrawn after the 2011 census. The final
piece of work in this thesis aims to address the problem of spatial mis-
alignment by proposing a multiple imputation approach which utilises a
common latent spatial grid. This approach is applied to data containing
hospital admissions for respiratory disease for the years 2006 - 2016 for
the health board Greater Glasgow and Clyde, where the data from 2013-
2016 are reported on the areas with redrawn boundaries. Overall, it was
found that there are still considerable health inequalities in Scotland at
both the small area level and between Scotland’s health boards. Although
these inequalities appear to be decreasing over time for cerebrovascular
and coronary heart disease, they are increasing for respiratory disease. In
particular, the risk of most areas which were estimated to have a high
risk of respiratory disease at the start of the time period are increasing
at a higher rate than areas with low risk. It was also found that areas
which experience high risk of one disease tend to experience high risk of
all three diseases studied here. This highlights the issue that Scotland
is facing and that more needs to be done to target the areas which are
experiencing high risk of disease across multiple diseases.
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Chapter 1
Introduction
Disease risk is not constant over space and time and is often impacted by exposure
to risk inducing behaviour such as consumption of alcohol. Poverty, and more gen-
erally deprivation, are major factors in the spatial variation observed in the risk of
disease, with more highly deprived areas usually exhibiting elevated levels of disease
risk (McCartney, 2012). This difference in disease risk between social groups and
population areas is known as a health inequality (or inequity). Importantly, health
inequalities refer to the unfair and avoidable differences in people’s health, and are
based largely on socio-economic factors such as income, wealth and education. They
are fundamentally driven and shaped by economics, social policy and politics, which
in turn lead to an unequal distribution of income, power and wealth. On a global level
the world’s poorest people tend to have the worst health, and so health inequalities
exist between countries. For example, the average life expectancy in Japan is 83.7,
compared to 50.1 in Sierra Leone (World Health Organization, 2016).
Health inequalities also exist to a large extent within countries, and are seen in
countries of all ranges of incomes. There is evidence which shows that individuals who
live at the poorer end of the socio-economic spectrum exhibit poorer health regard-
less of the wealth of the country (World Health Organization, 2008). The first major
report on health inequality in the UK was The Black Report (Black et al., 1982),
which was commissioned by the Labour Government in 1977. The report showed the
unequal distribution of ill-health and death across the UK, and concluded that these
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inequalities were due mainly to social inequalities affecting health. The Acheson Re-
port (Acheson, 1998) confirmed findings from The Black Report that the ‘weight of
scientific evidence supports a socio-economic explanation of health inequalities ’. Fol-
lowing the publication of these reports, it became widely recognised that social class
had a strong bearing on life expectancy. This is illustrated in Table 2.1 of Bartley
(2016), which shows standardised mortality ratios (SMR) by Registrar-General’s So-
cial Class (RGSC) in men aged 15-64, with an SMR for class I (professional) of 66
compared to 189 for class V (unskilled manual) in 1991. More recently, The Marmot
Review (Marmot, 2010) was published in 2010, and its key policy objectives focus on
the social determinants of health.
Reports such as these have aided the development of several social models which
differ from statistical models in that the aim is to explain the behaviours of the people
involved in a certain event or activity. Three of the most common models of expla-
nation for health inequalities, described in detail in Bartley (2016), are behavioural,
material and psycho-social. Very briefly, behavioural and cultural explanations refer
to the existence of health inequality due to differences in life-style between social
groups, most notably, smoking, exercising for leisure, and quantity of fats, sugars
and salt in the diet. The psycho-social model identifies the psycho-social risk factors
which impact health, including social support, autonomy at work and the balance
between home and work (Hemmingway and Marmot, 1999). The materialistic model
recognises the significance of ‘the...diffuse consequences of the class structure: poverty,
work conditions...and deprivation in its various forms in the home and immediate en-
vironment, at work, in education and the upbringing of children and more generally
in family and social life’ (Black et al., 1982). Much of the literature attempts to use
a combination of these three models when attempting to explain the causes of health
inequality.
In this thesis, I focus on estimating health inequalities in Scotland for several
reasons. First of all, Scotland has very poor health for a European country, with
the lowest and most slowly improving life expectancy compared to all other western
European countries (Walsh et al., 2016). This can be seen in Figure 1.1 which shows
the male and female life expectancy for Scotland in blue compared to 19 other western
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European countries in red from 1851 - 2005. Scotland also has the widest health
inequalities in western Europe (Popham and Boyle, 2011). For example, in 2015 it
was estimated that in the most aﬄuent areas in Scotland, men experience 23.8 more
years of good health, and women 22.6, compared to those living in the most deprived
areas (NHS Health Scotland, 2015). Although there was a major reduction in health
inequalities in Scotland between 1920 and 1970 (Beeston et al., 2013), clearly gaps
still exist between Scotland’s most aﬄuent and most deprived areas, and in some cases
these gaps are still widening. This is illustrated in Figure 1.2, which shows the average
life expectancy of males living in the vicinity of each stop of the Glasgow subway line
(Glasgow Open Data, 2010). The 15 stops on the Glasgow subway are distributed
over a 10km circuit which takes only 24 minutes to complete, and so the differences
in the life expectancies between some stops are substantial for what is a relatively
small geographical area. For example, at Hillhead the average life expectancy is 80,
which is 14 years higher than at Govan, only a 6 minute subway journey away. On
an individual level this is a tale of human tragedy, with too many Scots experiencing
poor health and dying prematurely as a direct result of health inequalities. These
inequalities in health also have huge economic repercussions for Scotland and place
an enormous burden on the NHS. For example, it has been estimated that if the
death rate across Scotland fell to the level of the least deprived areas, the economic
benefit could exceed £20billion (Audit Scotland, 2012).
Of all the problems facing Scotland, high mortality rates and gaping health in-
equalities are clearly of huge political and social importance, and reducing these
inequalities has been a priority for the Scottish Government for many years. In 2007
they established a Ministerial Task Force for Health Inequalities whose aim was ‘to
identify and prioritise practical actions to reduce the most significant and widening
health inequalities ’ (The Scottish Government, 2008). There have been many reports
by official bodies such as The Scottish Government, NHS Scotland and Audit Scot-
land (The Scottish Government, 2008, NHS Health Scotland, 2015, Audit Scotland,
2012) on Scotland’s health inequalities, with a focus on ways to reduce these in the
future.
Given the importance and extent of health inequalities across the globe, and
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Figure 1.1: Male and female life expectancy for Scotland (blue) compared to 19 other Western European Countries
(red) from 1851-2005 Plot source: Walsh et al. (2016). Data source: Human Mortality Database
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Figure 1.2: Map of the Glasgow subway with male life expectancies for each stop.
Source of subway map image: SPT Subway Maps & Stations page.
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more particularly in Scotland, there has been extensive research in this area. For
example, Taulbut et al. (2014) compared West Central Scotland with other post-
industrial regions of Europe, and Leyland et al. (2007) examined patterns in, and
causes of, inequalities for regions of Scotland. Comparisons between other European
countries and Scotland were the focus of Walsh et al. (2016), but they concentrated
on explaining Scotland’s, and particularly Glasgow’s, excess mortality. However,
this research collectively lacks an in-depth analysis of health inequalities for multiple
diseases at the small area scale in Scotland, which is the focus of this thesis.
In this thesis, I estimate health inequalities within Scotland at a small area level
to allow for a more in-depth understanding of where in Scotland these inequalities
exist and how they are changing over time. This general area of spatial epidemiol-
ogy is known as disease mapping and has been growing in popularity because of its
potential usefulness in regional health planning, disease intervention and allocating
health funding. It allows for the construction of smoothed spatial maps of disease
risk and the assessment of possible determinants of diseases. Most disease mapping
approaches tend to utilise data collected on non-overlapping areal units, such as cen-
sus tracts or electoral wards, as patient-level data cannot be made publicly available
due to patient confidentiality. However, studies at this small area level are often of
more use to health authorities as they are interested in risk levels across the whole
population.
The study region considered in this thesis is Scotland, which is the UK’s north-
ernmost country. The population of Scotland is around 5.4 million, and it con-
sists of a variety of different landscapes including highly populated cities, moun-
tainous wilderness and several small and sparsely populated islands. The small
area units for which data are available are known as intermediate geographies (IGs)
(http://www.gov.scot/Publications/2005/02/20732/53083), and many publicly
available datasets are published at this level. There are a total of 1235 IGs which, on
average, contain 4000 household residents. The geographical size of these IGs varies
widely and is dependent on the population density of the underlying area. Figure 1.3
shows a map of the IGs in Scotland and it can be seen that in the densely populated
‘central belt’ of Scotland, the geographical area of each IG is much smaller than the
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sparsely populated areas to the north. As well as quantifying health inequalities be-
tween IGs in Scotland, we are also interested in estimating the health inequalities
that exist between Scotland’s 14 regional NHS health boards, which are responsible
for the protection and improvement of their populations’ health and for the delivery
of frontline healthcare services. The 14 HBs are a range of sizes, both geographi-
cally and in terms of population, which can be seen from Figure 1.4. The estimated
population and number of IGs in each HB is provided in Table 1.1. The HBs with
the smallest populations are two of the island boards, Orkney and Western Isles,
with 2012 population estimates of 21,530 and 23,210 respectively. Greater Glasgow
and Clyde, and Lothian are the most populated HBs despite their relatively small
geographical area, with 2012 estimates of 1,217,025 and 843,733 respectively. This
is due to both of Scotland’s largest cities being situated in these HBs, Glasgow and
Edinburgh respectively, which can be seen from Figure 1.4. This shows that a large
land area does not imply a large population and instead the number of IGs is driven
by the population size rather than geographical size, with Greater Glasgow and Clyde
having the most IGs of all the HBs. In 2011/12 The Scottish Government allocated
around £170million to the health boards to address health inequalities, giving them
direct responsibility for tackling this problem (Audit Scotland, 2012). A key focus
of the research in this thesis is therefore to estimate the scale of health inequality in
disease risk between these health boards and investigate how this is changing over
time.
The first aim of this thesis will be to develop a single disease spatio-temporal
model to estimate health inequality at both the small area IG and larger HB level.
This methodology will then be extended into a multivariate setting using a novel
multivariate spatio-temporal model which will allow for health inequalities in multiple
diseases to be estimated in one model. This will fill a gap in the literature and provide
a clearer picture of overall health inequality in Scotland and how it has changed
over time. The methodology is applied to hospital admissions data for three of
Scotland’s biggest killers (Scotpho, 2016), namely, cerebrovascular disease, coronary
heart disease and respiratory disease from 2003 to 2012 across Scotland. Finally, it
is not uncommon for the boundaries associated with areal unit data to change over
6
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Figure 1.3: Map of the intermediate geographies in Scotland.
Table 1.1: Information on Scotland’s 14 health boards.
Health board Code Estimated population (2012) # of IGs
Ayrshire and Arran A 373,189 92
Borders B 113,707 29
Fife F 366,219 103
Greater Glasgow and Clyde G 1,217,025 272
Highland H 319,811 76
Lanarkshire L 572,520 137
Grampian N 573,420 128
Orkney R 21,530 6
Lothian S 842,733 177
Tayside T 411,749 90
Forth Valley V 299,099 74
Western Isles W 27,560 9
Dumfries and Galloway Y 150,828 35
Shetland Z 23,210 7
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A: Ayrshire and Arran
B: Borders
F: Fife
G: Greater Glasgow and Clyde
H: Highland
L: Lanarkshire
N: Grampian
R: Orkney
S: Lothian
T: Tayside
V: Forth Valley
W: Western Isles
Y: Dumfries and Galloway
Z: Shetland
Figure 1.4: Map of the NHS health boards in Scotland.
8
1. Introduction
the time period for which data are available. After the 2011 population census, the
Scottish Government decided to redraw the boundaries of the data zones which are
the key geography for small area statistics in Scotland and are used to create the
intermediate geographies that are used throughout this thesis. The redrawn data
zones were released in 2014 along with new boundaries for intermediate geographies.
Statistically, this poses a challenge since using data from before and after this change
would lead to non-comparable inference due to spatial misalignment of the IG data.
The final piece of work in this thesis aims to address this problem by using a multiple
imputation approach to undertake inference on a common grid for both sets of IGs,
thus producing comparable inference over time. This approach will then be applied
to data containing hospital admissions for respiratory disease for the years 2006 -
2016 for the Greater Glasgow and Clyde health board, where the data from 2013 -
2016 are reported on the redrawn IGs.
The remainder of this thesis is organised as follows. Chapter 2 provides an
overview of some of the existing methodology which will be used in this thesis
and provides a review of the relevant literature, with particular focus on spatial,
spatio-temporal and multivariate spatial/spatio-temporal methodology. In Chapter
3 a spatio-temporal hierarchical Bayesian model is developed and applied to data
containing coronary heart disease hospital admissions for the years 2003 to 2012.
The main aim of this chapter is to quantify health inequalities between both Scot-
land’s IGs and HBs and investigate how these have changed over time. The model
presented in Chapter 3 is then extended in Chapter 4 to provide a novel multivariate
spatio-temporal model to allow for health inequalities to be compared across three
diseases. Although estimating health inequalities between IGs and HBs within each
disease is still of interest, another key aim is to investigate if there any differences
in these health inequalities across the three diseases. In Chapter 5 a multiple im-
putation approach is developed to undertake inference on a common grid which will
allow for comparable inference over time when the spatial boundaries associated with
areal unit data change over time. The main aim of this chapter is to quantify health
inequalities in respiratory disease in Greater Glasgow and Clyde and investigate how
these have changed over a time period with a change in areal unit boundaries. Fi-
9
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nally, Chapter 6 provides a summary of the key findings of this thesis and possible
future work.
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Chapter 2
Literature Review
This chapter outlines the statistical methodology which is used throughout this thesis,
as well as giving an overview of the exisiting literature within these areas of statistics.
Section 2.1 introduces disease mapping which is an area of spatial epidemiology which
allows for disease risk to be estimated. Section 2.2 gives a brief overview of Bayesian
statistics, which is the statistical framework utlilised thorughout this thesis. Section
2.3 introduces generalised linear models (GLMs), with particular focus on GLMs for
count data. Some aspects of geostatistical modelling which are employed in this
thesis are described in Section 2.4. Sections 2.5 and 2.6 explore some of the existing
literature in spatial and spatio-temporal modelling which form the basis of Chapter
3. Sections 2.7 and 2.8 introduce existing methodology for multivariate spatial and
multivariate spatio-temporal models. Finally, Section 2.9 explores existing literature
used for continuous inference on aggregated data.
2.1 Disease Mapping
The risk of a particular disease can often vary over space, and geographic patterns of
disease can be attributed to many risk factors such as differences in environmental
exposures and in the behaviours of the inhabitants of different areas. As previously
mentioned, poverty and more generally deprivation are major factors in the spatial
variation observed in the risk of disease, with higher levels of disease risk generally
observed in more highly deprived areas (McCartney, 2012). In order to assess the
11
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extent and pattern of differences in disease risk over space, estimates of risk are
presented on a disease map which are computed by partitioning the study region
into n contiguous small areas and computing and then mapping the disease risk in
each area. The most popular way of illustrating differences in disease risk is via a
choropleth map where areas are shaded on a scale relating to disease risk. This area of
spatial epidemiology is known as disease mapping and has growing popularity because
of usefulness in regional health planning, disease intervention and the allocation of
health funding.
Most disease mapping approaches tend to utilise data collected on non-overlapping
areal units, such as census tracts or electoral wards, as patient level data cannot be
made publicly available due to patient confidentiality. In general, areal unit data are
data collected over a study regionA which is partitioned into n contiguous small areas
{A1, ...,An}. For each of these areas, a response is observed to give Y = (Y1, ..., Yn).
The naive approach would be to model disease risk using the disease counts Y =
(Y1, ..., Yn), however this ignores the substantial differences in the population sizes and
demographics which could account for some of the differences in the disease counts
between areas. Due to these differences in the demographic structures of each area,
expected counts ei for area i are usually calculated using indirect standardisation.
This is done by splitting each area into j = (1, ..., J) strata (for example ten year age
bands split by gender). The expected counts are then calculated by
ei =
∑
strata j
rjNji, (2.1)
where rj is the risk of disease for strata j for the entire study population and Nji
is the population size for strata j in area i. Based on these counts the simplest
measure of disease risk is the standardised incidence ratio (SIR), which is the ratio
of the observed counts and the expected counts of disease cases for each areal unit,
SIRi = Yi/ei. Values of SIR greater than 1 represent elevated levels of disease risk,
and values less than 1 correspond to decreased levels of disease risk, for example, an
SIR of 1.2 corresponds to a 20% increase in risk for that area. However, the SIR
can give unstable and uninformative estimates when the data includes areas where
12
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the expected numbers of disease cases are small. In order to overcome this issue a
hierarchical Bayesian modelling approach is typically adopted to estimate the risks,
using a combination of covariate information and a set of spatially varying random
effects. These random effects borrow strength from neighbouring areas which reduces
the chance of excesses in risk occurring randomly.
Although the geographical location of each areal unit is of direct interest, there
is no reason to believe that location itself would affect the risk of a certain disease.
Generally, the spatial location is a proxy measure of differences in the attributes of an
area such as social differences, e.g. consumption of alcohol, or differences in physical
or environmental geography, e.g. temperature or air quality. Some of these factors
may be known in advance to have an effect on the risk of disease and, if data are
available, can then be included in the model as a covariate. For example, a major
factor in health inequality is socio-economic deprivation, and so a measure of this is
often included in disease mapping models.
Spatial random effects are typically included in a model to account for any residual
spatial correlation left in the data after the covariate effects have been removed, and
can be seen as a surrogate for missing covariates (which are either unknown or unable
to be measured) that are correlated with location. Prior models are discussed for these
random effects in Section 2.5, but first an introduction to Bayesian modelling is given.
2.2 Bayesian statistics
2.2.1 Introduction
The notion of probability in a frequentist setting is attached only to repeatable ran-
dom events. Probabilities are never assigned to any fixed and unknown quantities.
So the observed data Y = (Y1, ..., Yn) are treated as a repeatable random sample
and the underlying parameters of interest, say θ, are assumed to remain fixed. Max-
imum likelihood methods are typically used to find parameter estimates based on
data collected from a sample of the population and often large sample properties or
asymptotic approximations are needed. For details see Garthwaite et al. (2006).
Compare this to a Bayesian framework where the parameters, θ, are treated as
13
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random variables. In other words, the uncertainty around the unknown parameters of
interest is represented probabilistically. This approach has origins from the mid-18th
century in Bayes’ Theorem which was developed by Thomas Bayes (Bayes, 1763) and
is defined as follows:
f(θ|Y ) = f(Y |θ)f(θ)
f(Y )
. (2.2)
Here f(θ|Y ) denotes the posterior distribution of the parameters given the data,
f(Y |θ) = L(θ) denotes the data likelihood, f(θ) denotes the prior distribution which
expresses our beliefs about the parameters before we see the data, and f(Y ) is the
normalising constant, which typically we don’t need to calculate explicitly. Therefore
we can rewrite Equation 2.2 up to a constant of proportionality as
f(θ|Y ) ∝ f(Y |θ)f(θ). (2.3)
The posterior distribution tells us everything we need to know about the parameters.
However, we may want to find summaries of this distribution. For example, central
point estimates can be found by taking the mean or median of the posterior distri-
bution. Unlike frequentist statistics, in Bayesian statistics we can make probability
statements about model parameters, and uncertainty in point estimates can be esti-
mated using interval estimates. For example, a credible interval is a range of values
that the parameter can take with a particular probability (say 0.95) and is found by
computing the end points of an interval that correspond with specified percentiles of
the posterior distribution (e.g. the 2.5th percentile and the 97.5th percentile).
Although Bayes’ theorem was proposed by Thomas Bayes in the mid-18th century,
the adjective ‘Bayesian’ was not part of statisical vocabularly until far more recently.
Many inferential methods which were based directly on the use of Bayes Theroem
were commonly referred to as ‘inverse probability’ up until the middle of the twenti-
eth century (Flenberg, 2006) and frequentist-based solutions were often not available
for complicated problems. However, from the 1950’s onwards there were huge ad-
vancements in computers and computing power which allowed solutions of complex
models to be found in a Bayesian framework, as it is now known. Today the choice
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between frequentist and Bayesian approaches is the subject of much debate among
statisticians. However, although the philosophical differences underlying both lead
to different approaches they can often yield similar results. The problems tackled in
this thesis will be approached using Bayesian hierarchical models as these can help in
understanding multiparameter problems and allow for models to be developed natu-
rally as levels of complexity are added. The following sections will summarise some
key aspects of Bayesian modelling.
2.2.2 Prior distributions
One of the biggest criticisms of the Bayesian paradigm is the use of prior distributions.
A frequentist will argue that choosing a very informative prior will necessarily bias
your results and if no information is known about the parameter then the choice of
the prior can be problematic. This section will outline some of the common types of
prior distribution used in practice.
Priors should be chosen before the data has been seen and often there may be some
prior information available from previous studies. In this case, the information can
be used to formulate an informative prior. Conversely, if nothing is known about the
parameter, then a weakly informative prior could be assigned. In this case, the pos-
terior distribution will be dominated by the likelihood function and estimated mainly
from the data. An example of a weakly informative prior for real valued parameters
would be a Gaussian distribution with a large variance, e.g. θj ∼ N(0, 10000).
Another important concept is the use of proper versus improper priors. If a prior
distribution does not integrate to a finite number when integrated over its range
space, it is an improper prior. For example, a uniform prior distribution on the real
line, f(θ) ∝ 1, for −∞ < θ < ∞. Although improper priors can lead to proper
posteriors, this is not always the case and care must be taken to check that the
posterior distribution is proper, as inference cannot be made with improper posterior
distributions.
Often priors are chosen through convenience, to make inference more easily achieved.
If a conjugate prior to the likelihood is chosen then the posterior will be of the same
distributional form as the prior and so will come from a standard distributional fam-
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ily. If this is the case, evaluation is more easily achieved as we are sampling from
a known distribution. Consider data Yi ∼ Poisson(λ) for i = 1, ..., n, an example
of a conjugate prior distribution for the parameter λ would be λ ∼ Gamma(α, β).
Here the posterior distribution will be of the same form as the prior, i.e. f(λ|Y ) ∝
Gamma(α +
∑n
i=1 Yi, β + n).
In this thesis, I will make use of both conjugate and weakly informative priors as
well as more informative priors which are based on our prior beliefs about the data.
2.2.3 Inference
Once the prior distribution has been chosen and an appropriate posterior distribution
has been derived, Bayesian inference relies on the ability to compute this posterior
distribution. In simple cases, closed form solutions of the posterior distribution may
exist or Monte Carlo approximation techniques can be used to provide a sample from
the distribution of interest. However, it is not always possible to sample directly from
a target distribution so instead more complex methods are used which generally rely
on approximating the posterior distribution in some way.
The most common method used to do this is a general class of algorithms called
Markov chain Monte Carlo (McMC), which provides dependent samples from the
‘target’ posterior distribution. Generally, a Markov chain with equilibrium distribu-
tion equal to the target distribution is constructed, draws are then simulated until
the Markov chain has converged, i.e. the current state of the Markov chain is approx-
imately a draw from the posterior distribution. There are two main ways to achieve
McMC simulation, Gibbs sampling (Geman and Geman, 1984) and the Metropolis-
Hastings algorithm (Hastings, 1970), which are both used in this thesis and are de-
scribed in the following sections.
2.2.3.1 Gibbs sampling
Suppose the parameter θ is partitioned as θ = (θ1,θ2, ...,θp), and we want to sample
from the joint posterior distribution f(θ1,θ2, ...,θp|Y ). Then if the full conditional
distribution for each θi, f(θi|θ−i,Y ), where θ−i = (θ1, ...,θi−1,θi+1, ...,θp), is known,
then we can use Gibbs sampling to sample from this distribution. Often conjugate
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priors, described in Section 2.2.2 are specified in order to use Gibbs sampling to
estimate the posterior distribution. The general algorithm for Gibbs sampling the
parameter θ is as follows.
1. Choose an initial value, θ(0) to start the chain. For t = 1, 2, ...
2. Let the current state of the Markov chain be θ(t) = (θ
(t)
1 , ...,θ
(t)
p ), then at time
t+ 1:
1. draw θ
(t+1)
1 from f(θ1|θ(t)2 , ...,θ(t)p )
2. draw θ
(t+1)
2 from f(θ2|θ(t+1)1 , ...,θ(t)p )
...
p. draw θ
(t+1)
p from f(θp|θ(t+1)1 , ...,θ(t+1)p−1 )
3. Increase t by 1 and repeat the above steps until we have the desired number of
draws.
2.2.3.2 Metropolis-Hastings algorithm
If, however, some or all of the full conditionals, f(θi|θ−i,Y ), are not from a known
family of distributions then the Metropolis-Hastings algorithm can be used to sample
from these distributions. The general recipe is as follows for a single block θi.
1. Initialise θ = θ(0). At step t = 1, 2, ...
1 Given the current point, θ
(t)
i simulate θ
∗
i from proposal distribution, gt(θ
∗
i |θ(t)i ).
2 Evaluate the acceptance ratio
r =
f(θ∗i |Y )gt(θ(t)i |θ∗i )
f(θ
(t)
i |Y )gt(θ∗i |θ(t)i )
. (2.4)
If the proposal distribution is symmetric, this can be reduced to the
Metropolis algorithm:
r =
f(θ∗i |Y )
f(θ
(t)
i |Y )
. (2.5)
3 Pick U ∼ Uniform(0, 1). If U < r, take θ(t+1)i = θ∗i , otherwise θ(t+1)i = θ(t)i .
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The proposal distribution gt(θ
∗
i |θ(t)i ) is used to propose new values for the parameters
based on their current values and can be chosen to be anything as long as it samples
from a valid range, for example a symmetric proposal distribution could be N ∼
(θ
(t)
i ,Σ), where θ
(t)
i is the current sampled value of θi. It is this which determines
how likely the new value is to be accepted. For example, if the proposed value is close
to the current value (proposal distribution has small variance) then the proposed
value is more likely to be accepted, whereas if the proposed value is very different
to the current value (proposal distribution has large variance) it is less likely to be
accepted. In general, the number of proposals which are accepted should not be
too high or too low. For example, Roberts and Rosenthal (2001) propose that for
random walk Metropolis on smooth densities, any acceptance rate between 0.1 and
0.4 should perform close to optimal. When the jumps made are very large each time,
the acceptance rate will be too low and the Markov chain could become stuck on
one value for long periods of time. Conversely, if the jumps made are too small,
the acceptance rate will be too high and the sampler will take too long to explore
the parameter space. In this thesis, this will be controlled by updating the proposal
variance every 100 iterations if the acceptance rate is deemed too high (greater than
0.4) or too low (less than 0.1).
2.2.3.3 Model convergence
In practice, often a combination of both Gibbs sampling and Metropolis-Hasting steps
are implemented to estimate posterior distributions for the parameters of interest in
a hierarchical Bayesian model. The number of draws that the sampler needs to run
for before the Markov chain has converged will depend on the complexity of the
underlying statistical model. In practice, a trial and error approach tends to be used
with convergence checked after the chain has been sampled for M draws. This is
a crucial stage of the process as inference is only valid after our Markov chain has
converged to our target distribution. We want to ensure that there are enough McMC
samples from high posterior density regions of our target distribution, i.e. that our
Markov chain has achieved stationarity and our Markov chain is therefore ergodic.
This then allows us to calculate the quantities of interest from our draws, ignoring the
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dependence between draws. We also want to ensure that the sampler moves between
the separate regions of high probability. This is known as mixing. One method is
to examine trace plots of the McMC samples for individual parameters, which show
the parameter values during the runtime of the chain and should show no trend. The
time taken for the chain to reach convergence is known as the burn-in period, and
these samples are discarded before inference is made as they are not representative
samples from the target distribution. Another tool for checking model convergence
is the Geweke diagnostic (Geweke, 1992), which is based on a test for equality of the
means of the first and last part of a Markov chain (usually the first 10% and the last
50%). The test statistic is a standard Z-score meaning that values between (-1.96
and 1.96) are indicative of convergence.
Another problem with McMC sampling is that the draws will show within chain
correlation since each draw is dependent on the previous value. Once convergence has
been checked, the burn-in discarded and the chain is now of length M , these samples
are not independent and therefore contain less information about the parameter than
M independent samples would, i.e. the effective number of independent samples is
far fewer than M . One suggested approach to tackle this is to thin the chain by
only keeping every kth simulation draw and discarding the rest. However it has been
argued that thinning is very wasteful of information, often unnecessary and increases
computation time (Link and Eaton, 2012). It can, however, be useful when computer
storage is a problem. For example, when the number of parameters is very large.
This is the case in this thesis and so thinning is used to produce samples closer to
independent and reduce the number of samples which need to be stored.
One of the disadvantages of McMC techniques, particularly for complex problems,
is that the algorithm can involve sampling a large number of parameters and so can
take a long time to run before a representative sample from each posterior distribution
has been drawn. One technique which can be used to speed up this process is blocking,
which involves constructing the sampler in a way that several parameters are drawn
at the same time. This should improve the efficiency of the sampler, particularly if
the parameters are correlated. However, as you increase the number of parameters
in the block and the dimensionality of the proposal distribution increases, it can be
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easy to miss important parts of the parameter space and acceptance rates generally
reduce.
2.3 Generalised linear models
Consider a linear regression model of the form:
E(Yi) = µi = x>i β, (2.6)
where;
• Yi∼N(µi, σ2), and are independent for i = 1, ..., n.
• xi = (1, xi2, ..., xip)> is the ith row of the design matrix,X, of known covariates.
• β = (β1, ..., βp)> is the unknown parameter vector.
This can be generalised to allow for a response variable which follows a distribution
other than normal, but which belongs to a very flexible class of distributions known
as the exponential family of distributions. Consider the random variable Y whose
probability distribution function (p.d.f) depends on the parameter θ. The distribution
belongs to the exponential family if it can be written as:
f(y|θ) = s(y)t(θ)ea(y)b(θ), (2.7)
or equivalently:
f(y|θ) = exp[a(y)b(θ) + c(θ) + d(y)], (2.8)
where s(y) = exp[d(y)] and t(θ) = exp[c(θ)].
Generalised linear models (GLMs) (Nelder and Wedderburn, 1972) include a re-
lationship between the response and the linear component of the form:
g(µi) = x
>
i β, (2.9)
where g is a monotone, differentiable function called the link function which describes
how the mean, E(Yi) = µi, depends on the linear predictor. What is of interest in a
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GLM are the parameters (β1, ..., βp) that describe how the response depends on the
explanatory variables.
2.3.1 Generalised linear models for count data
In this thesis, all the methodology is developed to model count data, such as numbers
of hospital admissions. The standard model used to represent data such as this is the
Poisson distribution. As previously discussed, due to differences in the demographic
structures of each areal unit disease risk cannot be modelled purely on the disease
counts, Y = (Y1, ...Yn), and so expected disease counts, e = (e1, .., en), are calculated
and now µi = eiθi, where θi is the disease risk for area i. Since the Poisson distribution
is a member of the exponential family of distributions, a generalised linear model can
be used to model these data. The general form is given by
Yi∼Poisson(eiθi), i = 1, ..., n, (2.10)
log(θi) = x
>
i β,
where the link function is the natural log and θi is the risk of disease in area i and
is on the same scale as the SIR defined previously. One of the key features of the
Poisson distribution is that the mean is equal to the variance, so
var(Y ) = E(Y ) = µ. (2.11)
However, often in practice we find that the variance is larger than the mean, which
is known as overdispersion. One way to overcome this issue is to use a quasi-poisson
distribution instead, which makes the less restrictive assumption that the variance
is proportional to the mean (McCullagh and Nelder, 1989). Another potential issue
with count data arises when working with data that contains an excess of zero counts,
for example rare disease data. In this case, it has been suggested that the excess zeros
are generated by a separate process than the counts and so a zero-inflated Poisson
model should be used, which uses a Poisson count model and a logit model for
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estimating the excess zeros (Lambert, 1992). In a frequentist setting, inference for
GLMs is typically achieved by using iteratively reweighted least squares to obtain the
maximum likelihood estimator (Dobson and Barnett, 2008), whereas in a Bayesian
setting the Metropolis-Hastings algorithm can be used.
2.4 Geostatistical modelling
Geostatistical modelling is a way of describing spatial patterns and interpolating
values for locations in space where data has not been observed. A geostatistical
process is a realisation of the stochastic process {Y (s) : s ∈ D} where s are the
locations where data could occur which vary continuously over the study region D ⊂
R2. However in practice, data are usually collected at a finite number of locations,
y = {y(s1), ..., y(sm)}.
A geostatistical process is defined to be Gaussian if the joint distribution of these
observations is multivariate Gaussian. In this case the process is completley defined
by its first two moments, E[y(s)] = µ(s) and Cy(s, t) = cov(y(s), y(t)).
A geostatistical process is weakly stationary if
1. E[y(s)] = µy(s) = µy for some finite constant µ which does not depend on s.
2. Cov[y(s), y(t)] = Cy(s, t) = Cy(h), where h = s− t.
Essentially this means that the mean is constant in space and the covariance function
between two points depends only on the distance and direction between them, and
not the locations themselves (Diggle and Ribeiro, 2007).
A weakly stationary geostatistical process is isotropic if the covariance function
can be further simplified to:
Cy(h) = Cy(||h||), (2.12)
where h = ||h|| denotes the Euclidean distance of the spatial lag h, i.e. the covariance
function depends only on the distance between two points and not the direction
(Diggle and Ribeiro, 2007).
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2.4.1 Covariance functions
Suppose we have a Gaussian weakly stationary and isotropic process such as:
Y ∼N(µ1,Σ(λ)). (2.13)
The spatial autocorrelation in the data is estimated via the covariance matrix Σ(λ),
where λ = (σ2, τ 2, φ). Here
• σ2 is the partial sill and represents the spatial variation in the data.
• τ 2 is the nugget and represents the non-spatial variation in the data.
• φ is the range parameter which measures how quickly the covariance decays to
zero.
Covariance functions can be used to account for the correlation between loca-
tions. The most commonly used covariance function in geostatistical modelling is the
exponential covariance function (Diggle and Ribeiro, 2007), defined by
Cy(h) =

σ2 exp(−h/φ), h > 0
τ 2 + σ2, h = 0
(2.14)
2.4.2 Kriging
Kriging was first proposed by Krige (1951) to predict spatial processes at new spatial
locations, s0. The approach is based on deriving the Best Linear Unbiased Prediction
(BLUP) for a new location given our current data y = (y(s1), ..., y(sm)). The BLUP
can be obtained by minimising the mean square prediction error (MSPE):
MSPE = E[(y(s0)− yˆ(s0))2]. (2.15)
It can be shown that the MSPE is minimised at yˆ(s0) = E[(y(s0)|y(s)]. This allows
for the application of the conditional distribution property of a multivariate Gaussian
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distribution (see A.1). Applying this property gives the joint geostatistical process
at the m data locations y = (y(s1), ..., y(sm)) and a new location y(s0) as:
 y(s0)
y
 ∼ N

 µy
µy1
 ,
 Cy(0,λ) Cy(s0,λ)>
Cy(s0,λ) Σ(λ)

 , (2.16)
where Cy(0,λ) = Var[y(s0)], Cy(s0,λ) = (Cy(||s1− s0||,λ), ..., Cy(||sn− s0||,λ) and
λ = (σ2, τ 2, φ)> are the parameters from the chosen covariance function Cy(). It then
follows that:
E[y(s0)|y] = µˆy +Cy(s0, λˆ)>Σ(λˆ)−1(y − µˆy1), (2.17)
and,
Var[y(s0)|y] = Cy(0, λˆ)−Cy(s0, λˆ)>Σ(λˆ)−1Cy(s0, λˆ). (2.18)
Equation 2.17 is called the Ordinary Kriging Predictor for an unknown, constant
mean. The same approach can be used to find the Universal Kriging Predictor which
can be used when the mean is non-constant and unknown.
2.5 Spatial modelling
Given that the direct modelling of the SIR can lead to unstable estimates of risk,
a common approach is to extend the Poisson GLM (2.10) to account for spatial
variation in the data. Given that these data are collected over space we would expect
to see spatial correlation between areas which are spatially close together. Spatial
correlation is induced into our modelling techniques via the neighbourhood matrix
W , which is an (n×n) normally binary matrix, where wij = 1 if two areas are defined
to be neighbours and wij = 0 if not. Given that an area cannot be neighbours with
itself, wii = 0 for all i. There are many ways to define if areas i and j are neighbours,
for example if they share a common border, if the centroids of the areas are within
a fixed distance d of each other or if area i is one of the k closest areas to area j in
terms of distance. In this thesis we define two areas to be neighbours if they share a
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common border.
The most common statistic to measure spatial correlation is Moran’s I (Moran,
1950), which is defined as follows:
I =
n
n∑
i=1
n∑
j=1
wij(Yi − Y¯ )(Yj − Y¯ )
n∑
i=1
n∑
j=1
wij
n∑
i=1
(Yi − Y¯ )2
. (2.19)
Moran’s I measures the strength of the linear spatial association in the areal data,
suitably weighted for their proximities. Potentially −1 < I < 1, where if I = −1
we have perfect dispersion, if I = 0 we have a random arrangement and if I = 1
we have perfect positive correlation. In reality we would expect a positive value of
Moran’s I, since areas close together are generally more likely to have similar values.
A permutation test is carried out to test the null hypothesis of no spatial correlation,
where the observed Moran’s I statistic is compared to Moran’s I statistics based on
K different random permutations of the data (which should give K values of Moran’s
I under independence). The estimated two-sided p-value for the test is
2
K + 1
K∑
k=1
I(Ik > |Iobs|). (2.20)
Here Iobs is the observed Moran’s I test statistic and I1, ..., Ik are the Moran’s I
statistics based on the K different random permutations of our data.
If the data contains significant spatial correlation, a popular way to model these data
is through a hierarchical Bayesian model with inference based on McMC simulation.
Given the convenient structure of hierarchical models, spatial correlation can be in-
corporated easily by extending the simple Poisson generalised linear model in Section
2.3 to a generalised linear mixed model with a set of spatially varying random effects
φ = (φ1, ..., φn) by
Yi∼Poisson(eiθi), (2.21)
ln(θi) = x
>
i β + φi,
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where xi = (1, xi2, ..., xip) is a p×1 vector of known covariates, including an intercept
term, with regression parameters β = (β1, ..., βp). Commonly the spatial random
effects are modelled via a conditional autoregressive (CAR) prior, which can be de-
fined by set of univariate full conditional distributions of the form f(φi|φ−i), where
φ−i = (φ1, ..., φi−1, φi+1, ..., φn). Many different CAR models have been proposed and
four of the most popular are detailed in the following sections.
2.5.1 Intrinsic CAR
The first CAR model prior was developed by Besag et al. (1991) and is given by
φi|φ−i∼N

n∑
j=1
wijφj
n∑
j=1
wij
,
τ 2
n∑
j=1
wij
 . (2.22)
Given that wij is only equal to 1 if two areas are defined to be neighbours, then
the conditional expectation of data point i is the mean of the data points in neigh-
bouring areas, and so each area is modelled as being similar to its neighbours. The
conditional variance also decreases as the number of neighbours increases, i.e. the
more neighbours an area has the lower the variance. This is natural since the more
neighbours an area has the more information there is about that area. Although this
seems a natural way to model these data, it only models strong correlation and does
not contain a correlation parameter which would allow for the strength of spatial cor-
relation to be estimated from the data. This prior is also undetermined for singleton
areas.
2.5.2 Convolution CAR
The convolution CAR was also delevoped by Besag et al. (1991) and is given by
26
2. Literature
φi = φ
(1)
i + φ
(2)
i
φ
(1)
i |φ(1)−i∼N

n∑
j=1
wijφ
(1)
j
n∑
j=1
wij
,
τ 21
n∑
j=1
wij
 (2.23)
φ
(2)
i ∼N
(
0, τ 22
)
.
Here φ is now a linear combination , with φ(1) assigned the intrinsic CAR prior and
the second set of random effects, φ(2), being independent and identically distributed
with mean zero and constant variance. This then overcomes the issue of the intrinsic
CAR prior inducing too much spatial smoothness by allowing this level to be deter-
mined by the ratio of the two variances τ 21 /τ
2
2 . However, the disadvantage of this
model is that each data point is now represented by two random effects and only the
sum, φ
(1)
i + φ
(2)
i , is identifiable.
2.5.3 Proper CAR
The model proposed by Stern and Cressie (2000) uses a single set of random effects but
allows for the level of spatial correlation to be estimated by introducing a correlation
parameter ρ. The full conditional distributions are given by
φi|φ−i∼N

ρ
n∑
j=1
wijφj
n∑
j=1
wij
,
τ 2
n∑
j=1
wij
 . (2.24)
Here ρ controls the level of spatial correlation in the data with ρ = 0 corresponding
to independence in space and ρ = 1 corresponding to strong spatial dependence. The
conditional variance is the same as the intrinsic CAR model. This model is essentially
the spatial equivalent of an AR(1) process in time series. The main issue with this
model is that when ρ is close to zero (indicating near independence in space), the
conditional variance is inversely proportional to the number of neighbours an area has.
However, ideally, in the absence of spatial correlation, the conditional variance would
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not decrease as the number of neighbours increases since having more neighbours
does not decrease the uncertainty about the value of an areas random effect.
2.5.4 Leroux CAR
This issue was addressed in the model proposed by Leroux et al. (2000) which is given
by
φi|φ−i∼N

ρ
n∑
j=1
wijφj
ρ
n∑
j=1
wij + (1− ρ)
,
τ 2
ρ
n∑
j=1
wij + (1− ρ)
 , (2.25)
again ρ controls the level of spatial correlation in the data. However now if ρ = 0,
the conditional variance simplifies to a constant, τ 2, and therefore the variance will
remain constant regardless of the number of neighbours an area has.
2.6 Spatio-temporal modelling
Now suppose that for each area in region A = {A1, ...,An}, the response is observed
over a period of t = 1, .., T years, resulting in the response vector Yi = (Yi1, ..., YiT )
for each area Ai. Data of this type are very common and lead not only to correlation
in space but also correlation in time.
The notion of separability is important in spatio-temporal statistics. If the sim-
plifying assumption of separability is made, the spatio-temporal covariance structure
can be separated into the product of two functions, one which depends only on space
and one which depends only on time. The following section describes some of the
spatio-temporal models proposed, of which some make this simplifying assumption.
It should also be noted that these models are described without covariates, however
the addition of these is trivial.
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2.6.1 Bernardinelli model
One of the first papers on space-time disease mapping was by Bernardinelli et al.
(1995), who proposed a hierarchical Bayesian model for the analysis of risk for a
given disease over space and time. The model proposed allows for analysis of data
collected over space and time by introducing a time effect along with a spatial effect.
The model proposed for θit (disease risk), where i (i = 1, ...n) is the area and t
(t = 1, ..., T ) is the time point, is as follows:
log(θit) = µ+ φi + (β + δi)t. (2.26)
Here µ is the overall intercept term and β is the overall slope parameter for the
linear time trend. The intercept can vary over space by the introduction of the
random effects φ = (φ1, ..., φn), as can the linear slope parameters via δ = (δ1, ..., δn).
Essentially, this model allows for a separate intercept and linear time trend for each
spatial area and hence a non-separable space-time structure.
Two separate prior distributions for φi and δi are proposed. The first is a nor-
mal distribution with mean 0 and variance σ2 used to model spatially unstructured
variation (i.e. independence). The second is an Intrinsic CAR prior used to model
spatially structured variation. This model also allows for correlation between the
slope and intercept by using an additional level in the hierarchical model. However
it should be noted that it may be inappropriate to restrict the time structure to be
linear, especially over long periods of time.
2.6.2 McNab and Dean model
An extension of this model was presented by MacNab and Dean (2002), who proposed
the use of B-spline trends over the temporal component. The model is of the form:
log(θit) = µ+ φi + α(t) + βi(t), (2.27)
where µ is the overall mean, φi is a random effect for area i, α(t) is an overall time
trend for all areas while βi(t) is an area specific deviation from this overall trend.
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As usual, a CAR prior is used for the spatial random effects and two specifications
are considered for modelling the temporal effects. Firstly, the overall trend, α, is
modelled using a cubic B-spline and the area specific trends are assumed to be linear.
The second proposed form uses cubic B-splines to model both components.
The models proposed here provide a flexible approach to modelling data with
complex spatio-temporal correlation structures. The use of both overall and area
specific trends allows for the estimation of the overall temporal structure observed
across the spatial region and the temporal structure of each individual area sepa-
rately, to identify areas which have a substantially different temporal trend than the
overall mean. Modelling the βi(t)
′s linearly, where appropriate, simplifies the model
considerably and allows for the random effects to be expressed linearly as φi + βit,
which has a simple interpretation with φi corresponding to the random effect over
space and βi being the temporal linear trend for area i on top of the overall temporal
trend (reducing to the Bernardinelli model).
However, the increased flexibilty of using B-spline smoothers for both the overall
and area specific trends results in a large increase in the number of parameters that
need to be estimated. Given that there are several possible alternatives for modelling
the temporal random effects, choices need to be made about which of the two temporal
structures to use. Also, for effects modelled using B-splines, the degree of polynomial
to be used must be chosen as well as how many and where to place the interior knots.
2.6.3 Knorr-Held model
The paper by Knorr-Held (2000) proposed a space-time hierarchical Bayesian model
with main effects and a space×time interaction. Rather than assume that the number
of disease cases or deaths Yit, for area i and time point t, follows a Poisson distribution,
Yit is assumed to have a binomial distribution with parameters nit and piit being the
number of persons at risk and the underlying binomial probability both for area i
and time point t respectively. The model proposed is as follows:
logit(piit) = µ+ φi + αt + γt + θi + δit, (2.28)
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where µ is the overall intercept, α = (α1, ..., αT ) and γ = (γ1, ..., γT ) are temporal
effects and θ = (θ1, ..., θn) and φ = (φ1, ..., φn) are spatial effects. Main effects γ and
φ have no temporal and spatial structure a priori, whereas blocks α and θ do have
temporal and spatial structure a priori, this model can therefore be thought of as the
spatio-temporal equivalent of the Convolution model described in Section 2.5.2. The
same model was proposed by Knorr-Held and Besag (1998) except for the introduction
of the interaction term δ = (δ11, ..., δnT ). The motivation for this more complex
model was to try and improve upon Bernardinelli et al. (1995) with a less restrictive
temporal trend and Knorr-Held and Besag (1998) with the additional allowance of
a space×time interaction term to allow for cases where variation in disease cannot
be modelled using separate space and time main effects, but an interaction between
these is necessary. The interaction parameters δit can follow one of four different
formulations, each corresponding to a different degree of prior dependence. These
are: (i) independent over space and time; (ii) independent over space but dependent
over time; (iii) independent over time but dependent over space; and finally (iv)
dependent over space and time. If all δit = 0, this term can be removed and a
separable model results.
This model formulation is beneficial because it is less restrictive than that pro-
posed by Bernardinelli et al. (1995) and also introduces a space×time interaction
which was not possible in the previous model proposed by Knorr-Held and Besag
(1998). It also allows for several space×time structures to be modelled by introduc-
ing four types of prior distribution for δ. Modifications can also be made to the
general specification if required, for example it may not be necessary to allow for
both structured and unstructured variation in space and time, which are computed
as Kronecker products of the spatial and temporal precision matrices. The interac-
tion term is also included in a way that allows the model to be simplified to just the
main effects if δ turns out to be negligible.
However, the general model formulation contains a large number of parameters,
four main effects plus one interaction, and therefore five variance parameters and
there may not be enough information in the data to reliably estimate them all.
31
2. Literature
2.6.4 Ugarte model
Ugarte et al. (2012) propose a similar model to that proposed by Knorr-Held (2000)
which is as follows:
log(θit) = µ+ αt + φi + δit, (2.29)
where µ is the overall intercept, αt are temporal effects, φi are spatial effects and δit
are space-time interactions. CAR type distributions for the spatial, temporal and
spatio-temporal interaction terms are assumed, namely a first order random walk for
αt, a Leroux CAR prior for φi and a normal prior for δit with mean 0 and a precision
matrix which is the Kronecker product of the precision matrices for the other two
effects. This formulation is more parsimonious than that proposed by Knorr-Held
(2000) as there are 2 fewer variance parameters to be estimated and 2 fewer sets of
random effects. Separability can also be tested by checking if the variance component
for δ is estimated to be 0 and if so, the interaction term can be dropped.
However, unlike the spatial effect, the temporal effect does not contain a correla-
tion parameter to allow for the strength of the temporal correlation to be estimated
and so this formulation is only suitable for modelling strong temporal correlation.
2.6.5 Rushworth model
The model proposed by Rushworth et al. (2014) is a less highly parametrised extension
of Ugarte et al. (2012) and is of the form:
log(θit) = φit, (2.30)
where φit are spatio-temporal random effects. Temporal correlation is induced by
allowing φt = (φ1t, ..., φNt), to depend on φt−1. The set of random effects for time
point 1, φ1, is specified using a Leroux CAR prior since φ0 does not exist and the
conditional specification for all other random effects is given by
φt|φt−1∼N(αφt−1, τ 2Q(ρ,W )−1) t = 2, ..., T, (2.31)
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where the precision matrix Q(ρ,W ) = ρ(diag(W1)−W ) + (1− ρ)I, where I is the
N ×N identity matrix and 1 is an N × 1 vector of 1s. Unlike the model proposed by
Ugarte et al. (2012), here α controls the level of temporal correlation which gives this
formulation the increased flexibility of modelling varying degrees of temporal correla-
tion. Another advantage is that only one variance parameter has to be estimated as
there is only one set of random effects used to capture residual spatio-temporal cor-
relation. In all other formulations, a variance parameter would have to be estimated
for each set of random effects.
However this particular specification can only be used for non-separable space-
time data given that the space, time and space×time effect are all represented by
one random effect which cannot simply be dropped if it turns out to be unnecessary.
There are also no space and time random effects to capture overall trends in the data.
2.7 Multivariate spatial models
So far the models introduced use data collected on one response variable of inter-
est. However, it may be of interest to model several response variables simultane-
ously using multivariate techniques. Now suppose that for each area in the study
region, A = {A1, ...,An}, more than one response is observed for each area, say
Yi = (Yi1, ..., YiD), where d = 1, ..., D denotes the different responses. Many multi-
variate models have been proposed in a purely spatial setting using multivariate CAR
(MCAR) spatial models, some of which are detailed in the following sections.
2.7.1 Kim model
Firstly, CAR models were extended by Kim et al. (2001) to the bivariate setting, by
proposing the following model with a two-fold CAR prior for the spatial effects
log(θid) = ψd + φid + id, (2.32)
φ∼N (0,Σ−1) ,
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where θid is the mortality rate for area i = (1, ..., n) and outcome d = (1, 2), ψd is a
disease specific intercept, φid is the spatial effect of the i
th region for the dth outcome,
and id is the extra variation effect where id ∼ N(0, σ2d) with σ2d assumed known.
The spatial effects φ = (φ1,φ2), where φ1 = (φ11, ..., φn1) and φ2 = (φ12, ..., φn2),
follow a multivariate normal with mean 0 and nonsingular covariance matrix Σ−1,
where
Σ =
 1δ1 (D − ρ1W ) − 1√δ1δ2 (ρ0I + ρ3W )
− 1√
δ1δ2
(ρ0I + ρ3W )
1
δ2
(D − ρ2W )
 . (2.33)
Here W is the usual neighbourhood matrix and D is an (n × n) diagonal matrix
defined by diag(2d1 + 1, ..., 2dn + 1), where di =
∑
j iwij, the number of neighbours
of region i. However this model is designed for the bivariate case and is not easily
generalised to higher dimensions.
2.7.2 Gelfand model
A more general formulation of MCAR models was proposed by Gelfand and Vounatsou
(2003), who proposed a number of models, one of the simplest given by
log(θid) = φid, i = 1, ..., n, d = 1, ..., D,
φ∼N
(
0,
[
Q(W , ρ)⊗Σ−1]−1) , (2.34)
where Σ is the between disease covariance matrix and the spatial correlation is in-
duced via the precision matrix
Q(W , ρ) = [diag(W1)− ρW ]. (2.35)
This MCAR model can be thought of as the multivariate equivalent of the proper
CAR detailed in Section 2.5.3. For a more comprehensive summary of the MCAR
literature refer to MacNab (2016).
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2.8 Multivariate spatio-temporal models
A natural extension of the MCAR models (as described in Section 2.7) is to allow
for multivariate data collected not only in space but also over time. Now assume
that for every area in region A = {A1, ...,An}, a response Yitd is observed for area
i = 1, ..., n, time period t = 1, ..., T and outcome d = 1, ..., D. Modelling techniques
for data of this kind will allow for information to be shared over space, time and
outcome, and should ensure that spatial, temporal and outcome correlation in the
data are accounted for. So far, the literature extending MCAR models to allow
for data collected over time is very limited. The following section contains details
on some of the multivariate spatio-temporal modelling techniques which have been
proposed.
2.8.1 Tzala and Best model
Of the few models proposed, some adopt Bayesian latent variable modelling. The
general idea behind this is to use correlation or covariances among a set of observed
variables and describe them in terms of a smaller set of latent variables. This approach
was adopted by Richardson et al. (2006) to model two diseases only. This framework
was extended to allow for more than two outcomes by Tzala and Best (2008), who
used factor analytic models applied to six diet-related cancers in Greece. The model
proposed is as follows:
log(θitd) = µitd, (2.36)
where the latent common factor is introduced as part of the model for µitd. The
paper gives three main formulations for this part of the model, the simplest of which
is a representation of a simple factor analysis model given by
µitd = λdfit. (2.37)
Here fit is the latent common factor and λd represents the factor loading for disease d.
The second model formulation proposed in Tzala and Best (2008) extends this model
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by allowing for disease specific spatial and temporal trends. In the third proposed
model in this paper, this formulation is extended by separating the common factor,
λd, into two individual components, one each for spatial and temporal structure
separately.
2.8.2 Quick model
An alternative to latent variable modelling is to extend the MCAR literature to allow
for data collected over space and time. A non-separable multivariate spatio-temporal
Bayesian model was proposed by Quick et al. (2017a). However, rather than model
the counts directly using a Poisson likelihood, they model the log of the disease rates
as Gaussian to avoid the computational burden that is associated with a Poisson
model. The proposed model, which follows on from Gelfand and Vounatsou (2003)
described in Section 2.7.2, is termed a multivariate space-time CAR (MSTCAR) and
is of the form:
ln(θitd) = x
>
i βd + Zitd + φitd, (2.38)
Z∼N (0, [Q(W )⊗Σ−1η ]−1) , (2.39)
where Z is a vector of random effects which account for spatio-temporal and between
outcome dependence, and φitd ∼ N(0, τ 2d ). Spatial correlation is induced via the
precision matrix
Q(W ) = [diag(W1)−W ], (2.40)
which is the multivariate equivalent to the Intrinsic CAR model described in Section
2.5.1. Here Ση is the LDU decomposition (decomposition of the form A = LDU
where D is a diagonal matrix and L and U are lower and upper diagonal matrices
respectively) comprising of temporal correlation and between outcome correlation
and allows for group-specific temporal correlation parameters and temporally varying
covariance matrices. Although using the normal approximation allows for computa-
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tional efficiency, it may not be appropriate if modelling data containing low rates of
incidence. This model was extended in Quick et al. (2017b) to a generalised linear
model setting to analyse age-specific stoke mortality data with a Poisson likelihood.
2.9 Continuous inference on aggregated data
So far, all of the models described make inference on the spatial distribution of dis-
ease risk for aggregated data relating to irregularly shaped non-overlapping areal
units. Data of this type are very common in disease mapping due to confidentiality
issues and so traditionally, models for discrete spatial variation, such as the CAR
models described earlier, are adopted to directly model the aggregated counts. Al-
though these models can be extremely useful to health authorities, one shortcoming
of traditional areal unit modelling techniques is that the areal units are themselves
artificial units of spatial recording and can influence the spatial pattern observed in
the data. That is, if the areal units changed then so would the results. This is known
as the Modifiable Areal Unit Problem (MAUP) and is a well known issue with dis-
crete spatial modelling (Heywood et al., 1998). Several studies of the MAUP have
been conducted (Fotheringham and Wong, 1991; Jelinski and Wu, 1996) which give
evidence of unreliability of analysis undertaken with data from areal units. Another
common problem in areal unit data of this type is that often there are changes to
boundaries that occur during the time period for which data are available. For exam-
ple, in 2014 The Scottish Government released a redrawn version of the intermediate
geography boundaries, and there are several data sets publicly available for which
the time period overlaps this boundary change. Using data from before and after
this change would lead to incomparable inference due to spatial misalignment in the
data, and needs to be dealt with. One way to overcome this issue would be to under-
take inference on a common latent spatial grid scale, and use a data augmentation
approach to estimate the unknown grid level counts on this scale. These grids can
be made arbitrarily small which leads to approximate continuous inference. From a
Bayesian perspective several approaches for this have been proposed.
The aim of Li et al. (2012a) was to make inference on the spatial distribution of
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syphilis risk in North Carolina using log-Gaussian Cox processes (LGCPs) to con-
struct spatially continuous maps of disease risk with the process being modelled on a
fine grid rather than the original census tracts. The spatial risk surface is modelled
as:
log(θ(s)) = µ+X(s)β + U(s), (2.41)
Cov[U(s), U(s+ h)] = σ2Mate´rn(|h|/φ, ν),
where θ(s) is the risk surface over space, X(s) is a vector of covariates measured at
each location in space and U(s) are spatial random effects. Here φ, ν are the range
and roughness parameters respectively and h is the distance between two points.
The continuous risk surface U(s) is approximated by a piecewise constant surface
evaluated on a regular lattice of squared grid cells. A data augmentation step allocates
the observed disease counts, Yr into counts per intersection of cell and areal units and
these are modelled as Poisson. A similar approach to these models was also taken by
Diggle et al. (2013).
The model proposed by Taylor et al. (2017) extends these models by adopting
spatio-temporal log-Gaussian Cox processes proposed in Taylor et al. (2015) and
applying these to aggregated areal unit data. The model proposed allows the risk
surface to vary over space and time as:
log(θ(s, t)) = X(s, t)β + U(s, t), (2.42)
where θ(s, t) is the risk surface over space and time, X(s, t) is a vector of covariates
measured at each location in space and time and U(s, t) are spatio-temporal random
effects. This paper also extends the data-augmentation methods developed in Li
et al. (2012a) and Taylor et al. (2015) to allow for continuous inference on spatio-
temporal areal unit data with overlapping and uncertain boundaries. Again inference
is made on a fine computational grid and there are many ways that the continuous
spatio-temporal surface could be modelled.
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For example Rostami et al. (2017) proposed a log-Gaussian Cox process to model
spatio-temporal variation of substance abuse mortality in Iran. Here a seperable
spatio-temporal risk surface was implemented of the form:
Cov[U(s, t), U(s′, t′)] = σ2Mate´rn(||s− s′||)ρ|t−t′|, (2.43)
where ||s−s′|| is the Euclidean distance between s and s′ and ρ denotes the temporal
correlation.
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Chapter 3
A single disease spatio-temporal
model to estimate changes in
health inequalities in coronary
heart disease across Scotland.
3.1 Introduction
The motivation for the work in this thesis is to estimate health inequalities across
Scotland. Although there have been many previous studies looking at health inequali-
ties in Scotland, many of them focus on comparisons either between large areas within
Scotland or between Scotland and other western European countries. Therefore, in
this chapter we propose a spatio-temporal model for quantifying health inequalities
in one disease in Scotland at a small area level using disease mapping techniques.
The disease we will focus on in this chapter is coronary heart disease, which is one of
the biggest killers in Scotland (Scotpho, 2016). The main focus is answering several
questions of interest:
1. Are there health inequalities in risk of coronary heart disease between Scotland’s
14 regional health boards and how are these changing over time?
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2. How are health inequalities changing over time in IGs in Scotland for coronary
heart disease risk?
3. What impact do the covariates have on disease risk?
We will present the results from our study and answer these questions of interest in
Section 3.5. However, first the data are presented in Section 3.2, while our proposed
model with health board specific auto-regressive temporal effects and a baseline CAR
prior for the spatial effects is presented in Section 3.3. Finally, Section 3.6 provides
a discussion on the conclusions drawn from this study and how it will be developed
in Chapter 4.
3.2 Data
3.2.1 Study region
As described in Chapter 1, the study region is Scotland which is split into n = 1235
intermediate geographies (see Figure 1.3) and H = 14 health boards (see Figure 1.4).
3.2.2 Disease data
The disease data are yearly counts of the numbers of hospital admissions for coronary
heart disease for the years 2003 to 2012 in each IG. For each year and intermediate
geography (IG) we have the number of admissions to non-psychiatric/non-obstetric
hospitals in Scotland with a main diagnosis of coronary heart disease which is defined
using the International Classification of Diseases Volume 10 (ICD10) codes (I20:I25).
The 10-year time period was chosen for a few reasons. Firstly, the data for these
years are freely available from the Scottish Statistics website, which is available on-
line at http://statistics.gov.scot/. Secondly, during this period The Smoking
Health and Social Care (Scotland) Act 2005 banned smoking in any enclosed pub-
lic space in Scotland from 26 March 2006 which is of interest since smoking has
been proven to increase the likelihood of an individual developing heart disease (U.S
Department of Health and Human Services, 2014). Finally, in 2007 The Scottish
Government set up a Ministerial Task Force for Health Inequalities. Given that both
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of these initiatives fall within or time period, we are interested in assessing if either
of them had a positive effect on reducing the health inequalities in coronary heart
disease in Scotland.
In order to adjust for age and sex differences in the populations in each IG, the
expected numbers of hospital admissions were calculated separately for each disease
using indirect standardisation based on age and sex adjusted rates for the whole of
Scotland. Given one of the goals of this analysis is to investigate temporal trends
in disease risk, the rates for the year 2006/07 were used to calculate the expected
values for all years. This will ensure that any changes in risk of coronary heart disease
are detected by the model rather than being incorporated into the expected values.
There is no reason to believe that this choice will have an impact on the results since
the disease studied here is chronic and therefore the risk for a population is unlikely
to change dramatically year to year. The year 2006/07 was chosen since it lies in the
middle of our time period. Letting i denote IG (i = 1, ..., 1235) and t denote year since
2003 (t = 1, ..., 10), the simplest measure of disease risk is the standardised incidence
ratio (SIR), θˆit = Yit/eit, where Yit is the observed number of hospitalisations and eit
is the expected number of hospitalisations. Values of SIR greater than 1 represent
elevated levels of disease risk, and values less than 1 correspond to decreased levels of
disease risk, for example, an SIR of 1.2 corresponds to a 20% increase in risk of coro-
nary heart disease. Figure 3.1 shows the SIR for coronary heart disease admissions
in IGs in Scotland from 2003 to 2012 firstly by year (panel(a)) and then by health
board (panel(b)). From the top plot, a decreasing trend in coronary heart disease
risk can be seen over the time period. In 2003 the median SIR is 1.177, whereas in
2012 this reduces to 0.765. There also seems to be a narrowing in the width of the
boxplots suggesting that the overall inequality in coronary heart disease risk may be
decreasing over time. When split by health board some variation in SIR can be seen,
with some HBs showing more spread in SIR than others and some differences in the
median level. In particular, the median SIR for Shetland (Z) is 0.666, and in contrast
the median SIR for Lanarkshire (L) is 1.097.
Figure 3.2 shows boxplots of the SIR in IGs for each HB at each time point.
From this it can clearly be seen that the risk of coronary heart disease is not constant
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Figure 3.1: (Top panel (a)) Boxplots of the standardised incidence ratio (SIR) for coronary heart disease admissions
for IGs in Scotland from 2003 to 2012 by year. (Bottom panel (b)) Boxplots of SIR for coronary heart disease
admissions for IGs in Scotland from 2003 to 2012 by health board. Red dashed line indicates a risk of 1.
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Figure 3.2: Boxplots of SIR for IGs in each health board at each year (2003-2012).
within a HB over the time period, for most HBs we see a decreasing trend over time.
However, the extent of the reduction in SIR differs between the HBs, with some HBs
showing a much stronger decrease than others. It can also be seen that the smaller
health boards such as Orkney (R) and Western Isles (W) show much larger changes
in the median level of SIR over time. This is due to these HBs having a very small
number of IGs (see Table 1.1) and so the number of admissions for these HBs are
small and therefore the data are more likely to show higher variation. From these
plots, there certainly seem to be differences in the risk of SIR between the health
boards and over time within health boards.
In order to assess the presence of spatial variation in the data, and how this has
changed over the time period, Figure 3.3 shows the SIRs across IGs in Scotland in
2003 and 2012. Firstly, the map of SIR in 2003 appears to have more areas with
high values of SIR than the map of 2012. This again suggests that risks of coronary
heart disease are going down from 2003 to 2012. Given that it is difficult to see any
pattern in the center of Scotland due to the high density of IGs, separate maps for
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the health boards Greater Glasgow and Clyde (G), Lothian(S) and Lanarkshire (L)
are shown in Figure 3.4. The decrease in overall risk is even more apparent from
these plots. The numbers of areas in 2012 with high risk has reduced significantly
compared to 2003, particularly in the west. This suggests that the decrease in risk of
coronary heart disease may be more rapid for areas in this part of Scotland compared
to the rest of Scotland. In both maps there are also far more areas with high risks in
the west of central Scotland compared to the east. Most of the areas in the east of
Glasgow city have SIRs of greater than one which is not surprising given that many
areas there are highly deprived. In general, Edinburgh seems to have fewer areas
with SIRs of greater than 1 compared to Glasgow. This stark difference in coronary
heart disease incidence between Scotland’s two major cities is a clear indication of
the issue of health inequality across Scotland.
3.2.3 Covariate data
Potential covariates were identified to help describe the spatial variation in disease
risk across Scotland. Firstly, the percentage of 16-64 year olds claiming job seekers
allowance (JSA), which is an unemployment benefit that can be claimed while look-
ing for work in the United Kingdom, is used as a proxy measure of deprivation since
it is well known that higher levels of socio-economic deprivation is linked to increased
disease risk (Audit Scotland, 2012). Given there is also evidence that a person’s
ethnicity can have an impact on the risk of certain diseases (The Scottish Govern-
ment, 2012), the percentage of the population of Asian ethnicity and the percentage
of the population of Black ethnicity were also included as potential explanatory vari-
ables. Both of these covariates are highly skewed to the right with lots of near
zero values, and so a log transformation was applied. Finally, an urban/rural factor
was included using the Scottish Government’s urban rural 2-fold classification which
can be found at http://www.gov.scot/Topics/Statistics/About/Methodology/
UrbanRuralClassification. This was chosen as an indication of access to hospitals
as perhaps those who live in rural areas are less likely to be admitted to hospital if
they live in remote areas where hospitals are difficult to reach.
Figure 3.5 shows plots of the four potential covariates and SIR. The top left figure
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Figure 3.3: SIR for coronary heart disease for each IG in Scotland in 2003 and 2012.
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Figure 3.4: SIR for coronary heart disease for each IG in health boards Greater Glasgow and Clyde (G), Lothian
(S) and Lanarkshire (L) in 2003 and 2012
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Figure 3.5: Scatterplots of the four potential covariates versus SIR. Top left: % claiming job seekers allowance. Top
right: log(% of population of Asian ethnicity). Bottom left: log(% of population of Black ethnicity). Bottom right:
Urban/rural indicator.
shows the relationship between SIR and the % of working age people claiming JSA
in each of the IGs for all years. There appears to be a positive linear relationship, i.e.
as the % claiming JSA increases, the SIR also increases. This indicates that areas
where a high percentage of the population claim JSA could experience an increase
in the risk of coronary heart disease. As previously stated, this relationship is to be
expected as there is evidence that higher levels of deprivation in an area increases the
risk of disease (Audit Scotland, 2012). The top right and bottom left plots show the
relationship between SIR and the log % of population of Asian and Black ethnicity
respectively, the natural logarithm of these covariates were taken as the data on the
original scale was skewed. Neither of the plots show an obvious relationship with
SIR, and so may not have any effect on the coronary heart disease risk of an area.
Finally, the bottom right plot shows boxplots of SIR for areas classed to be urban
and areas classed to be rural. The median SIR for urban areas is 0.992 whereas the
median SIR for of rural areas is 0.833 suggesting that there might be a slight increase
in risk of coronary heart disease for areas classed to be urban.
3.2.4 Exploratory analysis
In order to assess the presence of residual spatial correlation in the data, which
needs to be accounted for, a Poisson generalised linear model (GLM) was fitted to
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the data for the year 2003 with the covariates described before separately for each
disease. Moran’s I (Moran, 1950) statistics were then calculated using the residuals
from the model, and the results show that strong spatial correlation was present after
the covariate effects had been accounted for, with Moran’s I statistics of 0.227 with
significant associated p-value of < 0.001.
In order to assess the presence of temporal correlation, the average lag-one cor-
relation coefficient was calculated for each disease across the IGs. However, given
that we have a very short time series (only 10 time points) the results from this were
inconsistent. Although, given that the population from which the data come from
will remain broadly the same every year, a priori, we expect there to be temporal
correlation and so we will account for this in the final model.
3.3 Methodology
Here we outline a Bayesian hierarchical model for these data with the aim of quan-
tifying how health inequalities in coronary heart disease have changed over time in
Scotland and at the health board level.
3.3.1 Likelihood model
The standard likelihood model typically used in this context is given by
Yit ∼ Poisson(eitθit), i = 1, ..., n(= 1235); t = 1, ..., T (= 10),
ln(θit) = x
>
i β +Hh(i)t + φi, h(i) = 1, . . . , H(= 14), (3.1)
where Yit and eit are the observed and expected numbers of hospital admissions in
IG i and time point t, while θit is the risk relative to the expected numbers eit.
We model the log-risk with 3 components, the first of which is the p × 1 vector of
known covariates xi = (1, xi2, ..., xip), including an intercept term, with regression
parameters β = (β1, ..., βp). Given that we do not have access to temporally-varying
covariate information we cannot include this in the model. The prior specified is
β ∼ N(0, 100I) which is weakly informative to allow their values to be informed by
49
3. Single disease spatio-temporal model
the data. The remaining two components are a baseline spatial effect φi, and a health
board temporal trend Hh(i)t, where h(i) denotes that IG i is located within HB h.
Both of these components are described in the following sections. We have chosen not
to include temporal variation in the random effects φi, because we want all temporal
variation to be incorporated in the temporally varying health board effects as these
are of key interest.
3.3.2 Spatial effects
In Section 3.2.4, we found evidence of substantial residual spatial correlations in the
data, which we model via spatial random effects. Spatial correlation is induced into
these random effects via the neighbourhood matrix W , which is an (n × n) binary
matrix, where wij = 1 if two areas are defined to be neighbours and wij = 0 if not.
Also wii = 0 for all i. There are many different ways to specify if two areas are
neighbours, and the one used in this thesis is if two areas share a common border.
Geographically, Scotland comprises the northern one third of Great Britain along with
790 surrounding islands of which only 130 are still inhabited by people. Therefore,
there are several IGs which have no defined neighbours using this specification (6 in
total). This presents a major problem when estimating the spatial random effects
and so time was spent identifying these areas and connecting them to their closest
neighbour using the euclidean distance. There are also several groups of IGs which
are not connected to the mainland as the islands do not share a physical border with
mainland Scotland and so it was decided to connect these IGs to the nearest mainland
IG, again using euclidean distance. We model the spatial effects by a Leroux CAR
prior (Leroux et al., 2000) given by
φi|φ−i∼N

ρ
n∑
j=1
wijφj
ρ
n∑
j=1
wij + (1− ρ)
,
τ 2
ρ
n∑
j=1
wij + (1− ρ)
 , (3.2)
τ 2 ∼ Inverse-Gamma(0.001, 0.001),
ρ ∼ Unif(0, 1),
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where φ−i = (φ1, ..., φi−1, φi+1, ..., φn). The parameter ρ controls the level of spatial
autocorrelation in the data, with ρ = 0 corresponding to independence in space and
ρ = 1 corresponding to the intrinsic CAR prior (Besag et al., 1991, see Section 2.5.1).
The priors specified for hyperparameters τ 2 and ρ are weakly informative and allow
their values to be informed mainly by the data. The conjugate inverse-gamma prior
was used for τ 2 to allow this step to be implemented using Gibbs sampling.
3.3.3 Temporally varying HB effects
A key question in our analysis is to investigate the health inequalities between Scot-
land’s 14 regional health boards, and how these change over time. Therefore, we
include health board temporal trends in the model, Hh = (Hh1, ...,HhT ), which are
modelled by the first-order autoregressive process
Hht ∼ N(αHh,t−1, σ2), (3.3)
σ2 ∼ Inverse-Gamma(0.001, 0.001),
α ∼ Unif(0, 1),
where Hht is the effect for health board h and time point t. Temporal correlation is
induced via the hyperparameter α, with α = 0 indicating independence across time
while α = 1 indicates strong temporal dependence. A previous version of this model
allowed the hyperparameters α and σ2 to vary by health board, however in this case
the parameters were not well identified by the data, and so a simpler prior with single
parameters α and σ2 was implemented instead. As before, weakly informative priors
were assigned to α and σ2 to allow their values to be mainly informed from the data,
and both steps to be updated using Gibbs sampling.
3.4 Estimation
In order to obtain posterior summaries of each parameter, samples were drawn from
the posterior distribution using Markov chain Monte-Carlo (McMC) simulation using
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both Gibbs sampling and Metropolis steps. The McMC algorithm was written (as
part of this thesis) in R (R Core Team, 2014). However, due to the large number of
random effects that have to be sampled at each iteration, this step was implemented
using the R package Rcpp, which allows for this script to be run in the more efficient
language, C++ (Eddelbuettel and Franc¸ois, 2011, Eddelbuettel, 2013). Given that the
neighbourhood matrix W is a large but sparse matrix, we also utilised its triplet
form to speed up computation. Details of each step of the McMC sampler for Model
3.1 are shown in the following section.
3.4.1 Update for β
A Metropolis step is used to sample β given by
f(β|Y ,X,H,φ) ∝
n∏
i=1
T∏
t=1
Poisson(Yit|xi,β,H,φ)×
p∏
k=1
N(βk|0, σ2β), (3.4)
ln(f(β|Y ,X,H,φ)) ∝
n∑
i=1
T∑
t=1
(
yit(x
>
i β +Hh(i)t + φi)− exp(x>i β +Hh(i)t + φi)
)
+
p∑
k=1
(
− β
2
k
2σ2β
)
,
where β = (β1, ..., βp) is drawn as a single block for all 4 covariates. Each of the
continuous covariates were mean centered before being added to the model to remove
correlation between the parameter estimates and the intercept and allow for easier
interpretation of the HB effects.
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3.4.2 Update for φ
Each φi is drawn separately using a Metropolis step as follows:
f(φi|Y ,X,β,H) ∝
T∏
t=1
Poisson(Yit|xi,β,H,φ)×N(φi|φ−i), (3.5)
ln(f(φi|Y ,X,β,H)) ∝
T∑
t=1
(
yit(x
>
i β +Hh(i)t + φi)− exp(x>i β +Hh(i)t + φi)
)
− 1
2 τ
2
ρ
n∑
j=1
wij+(1−ρ)
φi −

ρ
n∑
j=1
wijφj
ρ
n∑
j=1
wij + (1− ρ)


2
.
Due to indentifiability issues, each φi was mean centered by health board.
3.4.3 Update for τ 2
τ 2 is drawn using a Gibbs sampler as follows:
f(τ 2|Y ,X,β,H,φ) ∝ N(0, τ 2Q(ρ,W )−1)× Inverse-Gamma(a, b), (3.6)
∝ Inverse-Gamma(a˜, b˜),
where,
a˜ = a+ n
2
,
b˜ = b+ 1
2
φ>Q(ρ,W )φ.
3.4.4 Update for ρ
Finally, ρ is drawn using a Metropolis step as follows:
f(ρ|Y ,X,β,H,φ) ∝ N(0, τ 2Q(ρ,W )−1), (3.7)
ln[f(ρ|Y ,X,β,H,φ)] ∝ 1
2
n∑
i=1
ln[ρei + (1− ρ)]− 1
2
φ>Q(ρ,W )φ
τ 2
,
where ei is a vector of eigenvalues from the matrix (diag(W1)−W ).
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3.4.5 Update for Hh
A Metropolis step is also used to sample the vector of H effects, given by
f(Hh|Y ,X,β,φ) ∝
n∏
i=1
T∏
t=1
Poisson(Yit|xi,β,Hh,φ)×N(Hh|0, σ2R−1), (3.8)
ln(f(Hh|Y ,X,β,φ)) ∝
n∑
i=1
T∑
t=1
(
yit(x
>
i β +Hh(i)t + φi)− exp(x>i β +Hh(i)t + φi)
)
+
(
−H
>
hRHh
2σ2
)
,
where Hh = (Hh1, ...,HhT ) is updated in a block for all time points in a health
board. There are therefore 14 separate updates (one for each health board) and
within each block, 10 parameters are proposed. The HB effects were mean centered
due to identifiability issues.
3.4.6 Update for σ2
σ2 is drawn using a Gibbs sampler as follows:
f(σ2|Y ,X,β,H,φ) ∝
H∏
h=1
N(0, σ2R−1)× Inverse-Gamma(c, d), (3.9)
∝ Inverse-Gamma(c˜, d˜),
where,
c˜ = c+ HT
2
,
d˜ = d+ 1
2
∑H
h=1H
>
hRHh.
3.4.7 Update for α
α is drawn using a Gibbs sampler as follows:
f(α|Y ,X,β,H,φ) ∝
H∏
h=1
N(0, σ2R−1)× Unif(0, 1), (3.10)
∝ N(µ, σ˜2),
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Posterior Median 95% CI
Spatial Autocorrelation 0.437 (0.325, 0.560)
Temporal Autocorrelation 0.875 (0.810,0.962 )
Table 3.1: Estimates and 95% credible intervals for autocorrelation in model.
where,
µ =
∑H
h=1
∑T
t=2Hh,tHh,t−1∑H
h=1
∑T
t=2H
2
h,t−1
,
σ˜2 = σ
2∑H
h=1
∑T
t=2H
2
h,t−1
.
3.5 Results
The spatio-temporal model proposed in Section 3.3 was applied to the data for Scot-
land described in Section 3.2. Inference is based on 150,000 McMC samples with a
burn-in period of 50,000. The chain was thinned by 5, due to limitations in com-
puter memory and to make the samples closer to independent, and so the posterior
estimates are based on a total of 20,000 samples. Convergence was checked both by
examining parameter trace plots and Geweke diagnostics (Geweke, 1992).
3.5.1 Spatial and Temporal Autocorrelation
Table 4.1 shows the posterior medians and 95% credible intervals for the autocorrela-
tion parameters in the model. First of all, the estimate for the spatial autocorrelation
parameter ρ is 0.437, this indicates there is moderate spatial autocorrelation in the
data. The temporal autocorrelation, α is estimated to be 0.875, which suggests rea-
sonably high temporal autocorrelation within the health boards.
3.5.2 Health board effects
In order to investigate whether there are health inequalities between Scotland’s 14
health boards and how these are changing over time (Question 1, Section 3.1), Figure
3.6 shows the posterior medians for each HB on the risk scale, θht = exp(Hht), for
coronary heart disease, after adjusting for the known covariates. It can be seen from
this plot that there are health inequalities between the HBs as there are differences
between the estimated HB posterior medians for coronary heart disease. The risk of
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Figure 3.6: Health board risk effects across time (θht = exp(Hht)). Posterior medians shown for all health boards.
The numbers at the top of each graph represent the range in the median HB effects for each year.
disease is not consistent between health boards, nor is it constant over time. However,
these inequalities are decreasing over time, with a difference of 0.716 between the
highest and lowest median HB risk in 2003 compared to 0.399 in 2012. Given that
the island boards are significantly smaller than the mainland boards we tend to see
greater variation in risk estimates for these boards over the time period. In fact, in
2003 the HB with the highest posterior median is Western Isles (W) and the HB
with the lowest posterior median is Shetland (Z), both of which are islands. It could,
therefore, be the case that the narrowing in health inequality between the health
boards is being driven by the highly variable island HBs. However, if these HBs are
removed the range in posterior medians in 2003 is 0.421 compared to 0.279 in 2012
so, even when ignoring the island boards, a reduction is still seen in health inequality
over time. Therefore, although there are still differences in the HB effects at the end
of the time period, it appears that these inequalities have reduced slightly from 2003
to 2012.
Figures 3.7 and 3.8 show the overall health board effects for each health board
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over time. These plots show the risk effects for the IGs belonging to each of the 14
health boards after the covariate effects have been removed. One of the main features
of these plots is that compared to the boxplots of the SIRs for each HB over time,
shown in Figure 3.2, the median lines are much smoother. This to be expected given
that the goal of a statistical model is to estimate the underlying trend in the data
rather than capture random noise and induced temporal autocorrelation. In general,
most HBs show a decreasing trend, as expected from the raw data, however there
are still differences in the trends between the HBs. For example, some of the HBs
have a decreasing trend at the beginning of the time period which then levels out
and remains reasonably constant at the end of the time period, e.g. Ayrshire and
Arran (A), Greater Glasgow and Clyde (G), Forth Valley (V) and Western Isles (W).
Whereas others show little change at the start of the time period and then begin to
decrease towards the end, e.g. Borders (B), Fife (F), Highland (H) and Grampian
(N). Some decrease fairly consistently over the entire period, e.g. Lanarkshire (L),
Orkney (R), Lothian (S) and Tayside (T). Finally, there are two boards whose trends
do not follow the general decreasing pattern, namely, Dumfries and Galloway (Y) and
Shetland (Z). For both these boards, the coronary heart disease risk remains slightly
below the null risk line of one for most time periods, which shows that, unlike the
other boards, the coronary heart disease risk effect associated with these boards is
low throughout the entire study period. There are also differences in the magnitude
of the change in trend. For example, there are some HBs whose risk at the start of
the time period is much higher, e.g. Greater Glasgow and Clyde (G), Lanarkshire
(L), Orkney (R), Tayside (T), Forth Valley (V) and Western Isles (W), all have high
median coronary heart disease risk estimates in 2003. By the end of the time period,
all of these HBs except from Orkney, have median risk plus 95% credible intervals
below the null risk line of 1 and so the change in coronary heart disease risk over
time is the most extreme for these boards. Finally, it should be noted that the
uncertainty around these estimates for some of the smaller boards (particularly the
island boards) is greater than for the larger HBs. This is to be expected given that
the boards with small numbers of IGs have much less data to estimate these effects.
In general, although these plots show decreasing trends across each of the 14 health
57
3. Single disease spatio-temporal model
1.0
1.5
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Year
D
is
ea
se
 R
is
k
A − Ayrshire and Arran
1.0
1.5
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Year
D
is
ea
se
 R
is
k
B − Borders
1.0
1.5
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Year
D
is
ea
se
 R
is
k
F − Fife
1.0
1.5
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Year
D
is
ea
se
 R
is
k
G − Greater Glasgow and Clyde
1.0
1.5
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Year
D
is
ea
se
 R
is
k
H − Highland
1.0
1.5
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Year
D
is
ea
se
 R
is
k
L − Lanarkshire
1.0
1.5
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Year
D
is
ea
se
 R
is
k
N − Grampian
1.0
1.5
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Year
D
is
ea
se
 R
is
k
R − Orkney
Figure 3.7: Health board risk effects across time (θht = exp(Hht)). Posterior medians in black with 95% credible
intervals shown by coloured dashed bands. Black dashed line indicates risk of 1.
boards, the shape of these trends is not consistent across HB. This indicates that
even after the covariate effects have been removed, there still appear to be differences
in coronary heart disease risk due to which health board each IG is located in.
3.5.3 Risk Maps
The risk estimates (posterior medians) are shown in Figure 3.9 for the years 2003,
2006, 2009 and 2012. A clear pattern can be seen with coronary heart disease risk
decreasing over the time period. In 2003, there are many areas in Scotland with
increased risk estimates, which can be seen clearly as the areas shaded in red. In
2006, although there are still some areas with increased risk of coronary heart disease,
the number has decreased. For the maps of 2009 and 2012, we now see that most
areas are shaded in blue which suggests that for most areas in Scotland, the risk of
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Figure 3.8: Health board risk effects across time (θht = exp(Hht)). Posterior medians in blackwith 95% credible
intervals shown by coloured dashed bands. Black dashed line indicates risk of 1.
coronary heart disease has decreased over time. When these risk maps are compared
to the maps of SIR in Figure 3.3 it should be noted that the estimated risk maps are
smoother than the raw SIR values. This is to be expected given the nature of spatial
smoothing where random effects borrow strength from their neighbours. Modelled in
this way the chance of extreme risks occuring is reduced. For example, over all IGs
and time points, the SIR for coronary heart disease ranges from 0.00 to 3.75, while
the corresponding model risk estimates range between 0.20 and 2.20.
The significance of disease risk for the same years is shown in Figure 3.10. Areas
shaded in blue have significantly lower disease risks than average (credible intervals
for θit that are less than 1), areas shaded in red have disease risks that are signifi-
cantly higher than average (credible intervals above 1) and areas in grey have credible
intervals that contain 1 and therefore show no significant difference in risk on average.
In 2003, only 14% of areas have significantly decreased risk of coronary heart disease,
33% contain the null risk of 1 and the majority of areas, 53%, have increased risk
effects. Compare this to 2012 where 74% of areas have significantly decreased risk
effects and only 4% of areas have significantly increased risk effects. From this we
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Figure 3.9: Risk estimates for coronary heart disease in IGs in Scotland in 2003, 2006, 2009 and 2012.
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can see huge changes in the risk of coronary heart disease in Scotland, with around
60% more areas exhibiting substantially decreased risk of coronary heart disease in
2012 compared to 2003.
3.5.4 Overall health inequalities
In order to investigate whether the overall health inequalities have changed over time
across the IGs in Scotland (and not just between HBs as in Section 3.5.2) (Question
2, Section 3.1), Figure 3.11 shows boxplots of the posterior median disease risk for all
IGs from 2003 to 2012. Most obviously from this plot, we see an overall decreasing
trend in the risk of coronary heart disease in Scotland from 2003 to 2012.
However, in order to assess changes in health inequalities, the variation in coronary
heart disease risk should be looked at rather than the median level. This will give
an indication into the difference between the areas with the lowest risk of coronary
heart disease and the areas with the highest risk. A reduction in health inequality
can be assessed either by looking for a narrowing in the width of the boxplots or
by a decrease in the interquartile range (IQR) which is printed in red above each
boxplot. It is quite clear from these plots that, not only is overall risk in coronary
heart disease going down in Scotland over time, but the inequality in coronary heart
disease risk is also decreasing, as the IQRs decrease year on year. This indicates that
the differences in coronary heart disease risk between population areas has reduced
from 2003 to 2012. It should also be noted that, not only are the boxplots narrower,
but the tails also reduce in length over time and the risk levels associated with the
outliers are much lower in 2012 compared with 2003. This tells us that we can also
see a decrease in risk in the areas which are the most at risk of coronary heart disease
and that the differences between the areas in the extremes of the risk levels are much
smaller in 2012. In fact, in 2003, the area with the highest risk of coronary heart
disease had a estimate of 2.187, i.e. this area was more than two times more at risk
of coronary heart disease than average, whereas in 2012 this estimate was reduced
to 1.567. This is important as it shows that not only is coronary heart disease risk
decreasing for the areas who had low or average levels of coronary heart disease risk
to begin with, but we are seeing this decrease in coronary heart disease risk over all
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Figure 3.10: Significance of the risk estimates for coronary heart disease in IGs in Scotland in 2003, 2006, 2009 and
2012. Areas shaded in blue have significantly lower disease risks (credible intervals for θit that are less than 1), areas
in grey have credible intervals that contain 1 and areas shaded in red have disease risks that are significantly higher
than average.
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Figure 3.11: Boxplots of risk for coronary heart disease in IGs in Scotland from 2003 - 2012. The IQR across IGs
are printed in red. Outliers are those observations that lie outside 1.5(IQR)
Covariate Median RR 95% CI
% 16-64 claiming JSA 1.062 (1.058, 1.067)
Log % Asian 0.985 (0.971, 0.999)
Log % Black 1.008 (1.002, 1.014)
Rural area 0.956 (0.929, 0.984)
Table 3.2: Relative risk estimates for a 1% increase in each covariate (not urban/rural covariate) and 95% credible
intervals for the covariates in model.
the IGs and, crucially, Scotland’s most vulnerable population.
3.5.5 Covariate effects
The effects of the covariates are displayed in Table 3.2. Presented are the estimates
(posterior medians) and 95% credible intervals on the relative risk scale (Question 3,
Section 3.1). The median relative risk (RR) for % 16-64 people claiming job seekers
allowance is around 1.062 for a 1% increase, so the risk of coronary heart disease
in an IG increases by 6.1% as the % claiming JSA increases by 1%. Since this is
the proxy measure of deprivation included in the model, it can be inferred that as
deprivation level increases, the risk of coronary heart disease also increases. The
63
3. Single disease spatio-temporal model
median RR estimate for log(% of population of Asian ethnicity) is 0.985, suggesting
that there may be a very small decrease in coronary heart disease risk as this covariate
increases. This result seems in line with findings from a Scottish Government report
(The Scottish Government, 2012) which found that those of Chinese ethnicity were the
least likely to be diagnosed with cardiovascular disease (which includes all diseases of
the heart and circulation including coronary heart disease) compared to the national
average. In that report, those in Indian and Pakistani ethnic groups showed no
difference compared to the national average. In this thesis, % of population of Asian
ethnicity includes all Asian ethnic groups, which could explain the small protective
effect for this covariate. The median RR estimate for log(% of population of Black
ethnicity) is 1.008 and the 95% interval is entirely above 1, although the lower bound
is very close to 1. This suggests a small increase in risk of 1% coronary heart disease
as log(% of population of Black ethnicity) increases by 1%. Although most reports
tend to find that those of Black ethnicity have lower risk of coronary heart disease, the
result here could be due to the fact that the % of population of Black ethnicity is very
low, the median value across all areas is only 0.25% and so there is very little data
to estimate this parameter reliably. Finally, the 95% credible interval for rural areas
compared to urban areas is entirely below 1 suggesting that areas which are rural are
likely to have a decreased risk of coronary heart disease compared to urban areas.
The risk associated with urban areas compared with rural areas is 1
0.956
= 1.046, i.e.
there is an estimated increased risk of coronary heart disease of 4.6% when living in an
urban area compared with a rural area. This result is in line with findings from recent
Scottish Government publication (The Scottish Government, 2015) which states that
the overall health of those living in rural areas is better compared to urban areas,
with male life expectancy being nearly 3 years higher for rural areas than the rest of
Scotland and the female life expectancy being nearly 2 years higher.
3.6 Discussion
In this chapter a hierarchical Bayesian model has been proposed to model the risk of
disease across Scotland and over time. The model included covariate effects, spatial
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random effects to allow for residual variation in space across the study area, and
health board effects which are allowed to vary over time. This model was applied to
hospital admissions data for coronary heart disease collected from 2003 to 2012 at
intermediate geography level.
Overall we have found that there are differences in coronary heart disease risk
across Scotland and these risks are also changing over time, with the median overall
risk decreasing from 1.156 in 2003 to 0.762 in 2012. These differences in risk between
population areas across Scotland are partly due to the covariates with increased
levels of the percentage of the population claiming job seekers allowance (a measure
of deprivation) inflating the risk of coronary heart disease by 6.1%, along with the
percentage of the population of Black ethnicity by 1.1%, however this covariate may
not be particularly well estimated given the very low percentages in the data, and
the percentage of the population of Asian ethnicity decreasing risk. It was also found
that living in a rural area compared to an urban area may have very small protective
effect on coronary heart disease risk.
Although looking for overall trends in disease risk is important, it is also crucial
to study the inequalities in disease risk, as often although an overall decrease is seen
in disease risk, the areas which are most at risk do not necessarily follow this trend
and so the inequality in disease actually increases. Here, however, we found that the
inequality in risk is also decreasing, with the IQR of risk estimates for IGs in each
year decreasing from 0.401 in 2003 to 0.256 in 2012, as shown in Figure 3.11. Given
the reasonably short time period used here, these reductions seem fairly considerable
given coronary heart disease is a chronic disease.
It has also been found that after adjusting for deprivation (and other covariates),
health inequalities in coronary heart disease risk still exist between the health boards,
although these have decreased over time. This can be seen most clearly from Figure
3.6, with the difference between the HB with the highest posterior median and lowest
posterior median being 0.716 in 2003 and 0.399 in 2012. Although all 14 HBs show a
decrease in coronary heart disease risk, the extent of this decrease varies hugely. The
HB which shows the largest decrease is Western Isles (W) whose posterior median
reduced by 0.764 over the 10-year period. Greater Glasgow and Clyde (G), Lanark-
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shire (L), Tayside (T) and Forth Valley (V) all showed a decrease of greater than 0.5
from 2003 and 2012. For the two HBs whose posterior median was below the null
risk of 1 in 2003, Dumfries and Galloway (Y) and Shetland (Z), although these HBs
showed a small decrease in risk effect, the extent was nowhere near as large as the
rest, which is to be expected, as they had less room to improve.
We were also interested in whether or not the smoking ban which came into effect
in 2006 or the set up of a Ministerial Task Force to tackle health inequalities in 2007
had any effect on the results. However, there is no compelling evidence to show that
either of these have made a significant impact since the reduction in risk of coronary
heart disease started before the ban and Taskforce were implemented. However, data
is only available until 2012 and these initiatives may not have had time to impact
coronary heart disease risk yet. A further study over a longer time period may be
required to investigate any potential lagged effects of the introduction of both the
smoking ban and the Ministerial Task Force.
This methodology allows us to compare health inequalities in Scotland overall
and between the 14 regional health boards for a single disease, in this case coronary
heart disease. Although this same approach could be adopted for other diseases,
investigating just one disease at a time ignores any correlation between diseases and
will give an incomplete picture of overall inequality. Therefore, in Chapter 4 we
propose a novel multivariate spatio-temporal model to quantify health inequalities in
Scotland across 3 major diseases, which will enable us to better understand how they
have changed over time. A multivariate approach is also beneficial as it will allow
the model to borrow strength not only between neighbouring areas and time points
as in the model proposed in this chapter, but also between disease.
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Chapter 4
A multivariate model for
estimating the changes in health
inequalities across Scotland over
time
4.1 Introduction
Measuring a population’s health and the inequalities between population areas is
an extremely complex problem. Therefore, the simplistic approach in Chapter 3,
where a single disease is used to estimate health inequality does not seem adequate.
This chapter extends this simple, univariate disease risk model to a more realistic
multivariate disease risk model, where multiple diseases are investigated to better
understand how health inequalities have changed across Scotland during the time pe-
riod 2003 - 2012, using data containing hospital admissions for two more of Scotland’s
biggest killers (Scotpho, 2016), namely cerebrovascular disease and respiratory dis-
ease. Studying these diseases simultaneously with coronary heart disease will provide
a better understanding of the relationships that exist between them.
As discussed in Section 2, very few multivarate space-time models have been pro-
posed for modelling the risk of multiple diseases in space and time simultaneously
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and so this chapter proposes a novel spatio-temporal multi-disease model for quanti-
fying health inequalities in Scotland. The main focus is answering several questions
of interest:
1. Are there health inequalities between Scotland’s health boards and how are
these changing over time?
2. Within a health board, how do average risk levels and temporal trends change
between diseases?
3. How are health inequalities changing over time in IGs in Scotland across mul-
tiple diseases?
4. What impact do the covariates have on risk and how does this change by dis-
ease?
5. Are there some areas which have high risk for all three diseases?
We will present the results from our study and answer these questions of interest in
Section 4.5. However, first the data are presented in Section 4.2, while our proposed
model, which is a multivariate extension of the model proposed in Chapter 3, is
presented in Section 4.3. Finally, Section 4.6 provides a discussion on the conclusions
drawn from this study and possible ways in which it could be developed.
4.2 Data
Similar data as described in Chapter 3 is also held for cerebrovascular disease and
respiratory disease. These data are the yearly counts of the numbers of hospital ad-
missions for the period 2003 to 2012. For each year and IG we have the number of
admissions to non-psychiatric/non-obstetric hospitals in Scotland with a main diag-
nosis of each disease for both sexes and all ages combined. Cerebrovascular disease
is defined using the International Classification of Diseases Volume 10 (ICD10) codes
(I60:I69, G45), while the codes are (J00:J99, R09.1) for respiratory disease. Ex-
pected numbers for both diseases were also calculated using indirect standardisation,
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using age and sex adjusted rates for the year 2006/07, which were obtained from the
Information and Services Division of the NHS.
For consistency, the same covariates used in Chapter 3 are included here, which
are, the percentage of 16-64 year old’s claiming job seekers allowance (JSA), the
percentage of the population of Asian ethnicity, the percentage of the population of
Black ethnicity and an urban/rural factor.
4.2.1 Exploratory analysis
The simplest measure of disease risk, the SIR, is a good way to informally explore
risk patterns in the data. This section will provide some exploratory insight into the
inequality in risk for coronary heart disease, respiratory disease and cerebrovascular
disease.
Figure 4.1 shows boxplots of SIR by year and by health board for cerebrovascular
disease, coronary heart disease and respiratory disease. For all three diseases, different
patterns over time can be seen. As seen in Chapter 3, a decreasing trend can be
seen over time for coronary heart disease. A decreasing trend can also be seen for
cerebrovascular disease, however, it is much more gradual than that for coronary
heart disease. Conversely, for respiratory disease, an increasing trend can be seen
over the time period, suggesting that risk of respiratory disease is getting worse in
Scotland over these years. When SIR is split by health board, some variation between
the HBs can be seen. For each disease, there are some HBs whose median line sits
above the null risk line and some whose median line sits below this line. For example
for respiratory disease, Ayrshire and Arran (A), Greater Glasgow and Clyde (G)
and Lanarkshire (L) all have median lines above the null risk line, and the rest of
the HBs have median lines below the null risk line. This indicates that there may
be health inequalities between the HBs within each disease. When comparing these
plots between disease, there are some similarities, e.g. the median risk for Borders
(B), Fife (F), Highland (H), Grampian (N), Orkney (R), Lothian (S), Dumfries and
Galloway (Y) and Shetland (Z) is clearly below the null risk line for all three diseases,
suggesting these boards have lower risk for all diseases on average over the 10 years.
However, there are also some HBs where the plots show some discrepancies across
69
4. Multi-disease spatio-temporal model
0
1
2
3
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Year
SI
R
(a)
0
1
2
3
A B F G H L N R S T V W Y Z
Health Board
SI
R
(b)
Cerebrovascular Disease
0
1
2
3
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Year
SI
R
(a)
0
1
2
3
A B F G H L N R S T V W Y Z
Health Board
SI
R
(b)
Coronary Heart Disease
0
1
2
3
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Year
SI
R
(a)
0
1
2
3
A B F G H L N R S T V W Y Z
Health Board
SI
R
(b)
Respiratory Disease
Figure 4.1: (a) Boxplots of the standardised incidence ratio (SIR) for cerebrovascular, coronary heart disease
and respiratory disease admissions for IGs in Scotland from 2003 to 2012 by year. (b) Boxplots of the SIR for
cerebrovascular, coronary heart disease and respiratory disease admissions for IGs in Scotland from 2003 to 2012 by
health board. Red dashed line indicates a risk of 1.
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the three diseases. For example, for Greater Glasgow and Clyde (G), the median is
clearly above 1 for respiratory disease and cerebrovascular disease, but on the line for
coronary heart disease. Similarly for Lanarkshire (L), the median line is above 1 for
two of the three diseases (coronary heart disease and respiratory disease) but on the
line for one (cerebrovascular disease). This shows that although for some HBs the
patterns in risk may be similar across disease, this is not necessarily the case for all
HBs.
To allow us to investigate how disease risk changes over time within HBs and
whether these changes are consistent across HB and over the three diseases, Figure
4.2 shows boxplots of SIR split by HB and year for each disease. The first thing to
note is that similar trends can be seen across some of the HBs in each disease, for
example many of the HBs for cerebrovascular disease and coronary heart disease have
decreasing trends, whereas for respiratory disease many of the HBs have an increasing
trend. However, not all of the HBs within a disease follow these general patterns, e.g
for respiratory disease Highland (H), Grampian (N), Forth Valley (V), and Dumfries
and Galloway (Y) all seem to have reasonably constant risks over the time period,
whereas the rest of the HBs seem to have increasing SIR values over time. As touched
on previously, an important feature of these plots is that, when comparing each HB
across the three diseases, the patterns shown are not always similar. For example
when looking at Greater Glasgow and Clyde (G) the trend over time is strong and
decreasing for coronary heart disease, strong and increasing for respiratory disease
and although decreasing again for cerebrovascular disease, the extent of this decrease
is much more gradual than for coronary heart diease. This is a good example of
why looking at more than one disease is important in this situation, since there are
some differences in the relationships observed across disease which may prove to be
important when drawing conclusions about how health inequalities have changed
across Scotland over time. Finally, the plots show much more variability over time
for the three island HBs, Orkney (R), Western Isles (W) and Shetland (Z), due to
the small number of IGs in these HBs.
In order the assess the presence of spatial variation in the data for each disease,
Figure 4.3 shows the SIRs across IGs in Scotland in 2006 for cerebrovascular disease,
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Figure 4.2: Boxplots of Standardised Incidence Ratios (SIR) for cerebrovascular disease, coronary heart disease and
respiratory disease for IGs in each health board at each year (2003-2012).
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Figure 4.3: Standardised Incidence Ratios (SIR) for cerebrovascular disease, coronary heart disease and respiratory
disease for each IG in Scotland in 2006.
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coronary heart disease and respiratory disease. From these maps we can see that the
spatial patterns for each disease are not the same. Both cerebrovascular disease and
coronary heart disease have more areas in northern Scotland with high disease risk
than respiratory disease. This suggests having disease specific spatial risk surfaces in
the modelling.
Due to the large number of IGs located in central Scotland, it is difficult to
see any pattern for this part of Scotland in these maps. Figure 4.4 shows separate
maps for HBs Greater Glasgow and Clyde, Lothian and Lanarkshire, which are all
located in central Scotland, to give a clearer picture of spatial patterns in these areas.
One similarity between these three maps is that there are more areas in the west of
Scotland which show SIR levels of above 1 compared to the east, particularly in the
city of Glasgow. As seen in the maps for all of Scotland, the spatial patterns for each
disease are not the same, again suggesting disease specific spatial risk surfaces.
In this study, a multivariate approach has been deemed suitable given the difficulty
in measuring a population’s health. It is therefore assumed that using a combination
of data from three of Scotland’s biggest killers would provide a better understanding
of health inequalities in Scotland rather than just concentrating on a single disease.
The hospital admissions for these three diseases are therefore our dependent variables.
Figure 4.5 shows scatterplots of the three diseases plotted against one another to give
a better understanding of the relationship between these diseases. From these plots,
and the correlations which are printed on the top-right corner of each graph, we
can see that for all combinations of the three diseases there are moderate positive
relationships between them with correlations of around 0.5. These correlations are
assumed to be caused by common factors which further justifies the reasoning to
use a multivariate approach to model health inequality, since all three diseases are
related to one another but including each will provide different information to better
estimate health inequalities in Scotland.
In order to assess the presence of residual spatial correlation in the data, a Poisson
generalised linear model (GLM) was fitted to the data for 2003 for each disease
separately, with the covariates described. Moran’s I (Moran, 1950) statistics were
then calculated using the residuals from these models, and the results show that for
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Figure 4.4: Standardised Incidence Ratios (SIR) for each IG in health boards Greater Glasgow and Clyde, Lothian
and Lanarkshire in 2006 for cerebrovascular, coronary heart and respiratory disease.
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Figure 4.5: Scatterplots to show the relationship between each of the three disease. Correlations are printed in the
top right of each plot.
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all three diseases strong spatial correlation was present, with Moran’s I statistics of
0.107, 0.227, and 0.241 for cerebrovascular, coronary heart and respiratory disease
respectively, with significant associated p-values < 0.001 for all 3 statistics.
Pairwise correlations were also calculated between the residuals for each disease,
with a correlation of 0.211 between cerebrovascular and respiratory disease, 0.216 be-
tween cerebrovascular and coronary heart disease and 0.337 between coronary heart
and respiratory disease. This indicates that there is some residual between disease
correlation in the data, suggesting between disease correlation needs to be modelled.
To investigate whether disease specific covariate effects would be appropriate, the
estimated covariate effects from the same Poisson GLM’s as before were checked and
some differences in these were found. For example the covariate log(% of population
of Asian ethnicity) showed a significant protective effect for coronary heart disease, a
significant increased risk effect for respiratory disease and no significant effect for cere-
brovascular disease. It is therefore appropriate to include separate covariate effects
for each disease.
Finally, in order to assess the presence of temporal correlation, the average lag-one
correlation coefficient was calculated for each disease across the IGs. However, given
that we have a very short time series (only 10 time points) the results from this were
inconsistent. Given that the data come from the same group of people every year, a
priori, we would expect there to be temporal correlation and so we will account for
this in the final model.
4.3 Methodology
Here, we outline the multivariate spatio-temporal model developed to answer the
questions of interest in this chapter. To extend the model used in Chapter 3 to account
for multiple diseases, between disease correlation needs to be incorporated into the
model. Similar to before, a hierarchical Bayesian model based on observed counts
of hospital admissions, Yitd, letting i denote IG (i = 1, ..., 1235), t denote year since
2003 (t = 1, ..., 10) and d denote disease (d = 1−cerebrovascular disease, 2−coronary
heart disease, 3−respiratory disease). Expected counts, eitd, for area i, time point t
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and disease d were calculated using standardisation to account for differences in the
demographic structures of each area.
4.3.1 Likelihood Model
The first level of the hierarchical model we specify is given by
Yitd ∼ Poisson(eitdθitd), i = 1, ..., n(= 1235); t = 1, ..., T (= 10); d = 1, 2, D(= 3),
ln(θitd) = x
>
i βd +Hh(i)td + φid, h(i) = 1, . . . , H(= 14), (4.1)
where Yitd and eitd are the observed and expected numbers of hospital admissions in
IG i, time point t and disease d, while θitd is the risk relative to the expected numbers
eitd. We model the log-risk with 3 components, the first of which is the p× 1 vector
of known covariates xi = (1, xi2, ..., xip), including an intercept term, with disease
specific regression parameters βd = (β1d, ..., βpd). Given that we do not have access
to temporally-varying covariate information we cannot include this in the model.
However, we did consider allowing the regression parameters to vary over time and
disease, i.e βtd = (β1td, ..., βptd) but the parameter estimates showed little change over
time and the results can be found in Appendix B, Section B.1. The prior specified is
βd ∼ N(0, 100I) which is weakly informative to allow their values to be informed by
the data. The remaining 2 components are a baseline disease specific spatial effect
φid, and a disease specific health board temporal trend Hh(i)td, where h(i) denotes
that IG i is located within HB h. Both of these components are described in the
following sections.
4.3.2 Disease specific spatial effects
In Section 4.2.1, we found evidence of substantial residual spatial correlations in the
data, which we model via disease specific spatial random effects. Spatial correlation
is induced into these random effects via the neighbourhood matrix W , which is an
(n × n) binary matrix, where wij = 1 if two areas are defined to be neighbours and
wij = 0 if not. Also wii = 0 for all i. We use the same neighbourhood matrix W as
in Chapter 3, i.e. the way we define if two areas are deemed to be neighbours is if
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they share a common border.
Since there was evidence from Figure 3.3 that a common spatial surface may not
be appropriate for all diseases, we model the multi-disease spatial effects φ by a
multivariate version of the Leroux CAR prior (Leroux et al., 2000) given by
φi|φ−i∼N

ρ
n∑
j=1
wijφj
ρ
n∑
j=1
wij + (1− ρ)
,
1
ρ
n∑
j=1
wij + (1− ρ)
Σ
 , (4.2)
Σ ∼ Inverse-Wishart(3, I),
ρ ∼ Unif(0, 1),
where φi = (φi,1, ..., φi,D) and φ−i = (φ1, ...,φi−1,φi+1, ...,φn). The parameter ρ
controls the level of spatial correlation in the data, with ρ = 0 corresponding to
independence in space and ρ = 1 corresponding to the multivariate extension of
the intrinsic CAR prior (Besag et al., 1991). Disease-specific spatial correlation, ρ =
(ρ1, ρ2, ρ3), was considered but analyses on each disease separately suggested a single ρ
parameter was sufficient. The covariance matrix, Σ, is included to allow for between
disease correlation. Given there is no particular reason for an a priori structure
for this matrix, an unconstrained form is assumed. The conjugate inverse-Wishart
prior is assigned to Σ to allow this step to be implemented using Gibbs sampling,
with weakly informative hyperparameters which will allow for these parameters to be
estimated mainly by the data.
4.3.3 Temporally varying HB effects
A key question in our analysis is to investigate the health inequalities between Scot-
land’s 14 regional health boards, and how these change over time and between dis-
ease. Therefore we include disease specific health board temporal trends in the model,
Hhd = (Hh1d, ...,HhTd), which are modelled by the first-order autoregressive process
79
4. Multi-disease spatio-temporal model
Hhtd ∼ N(αdHh,t−1,d, σ2d), (4.3)
σ2d ∼ Inverse-Gamma(0.001, 0.001),
αd ∼ Unif(0, 1),
where Hhtd is the effect for health board h at time point t for disease d. Temporal
correlation is induced via the hyperparameter αd, with αd = 0 indicating indepen-
dence across time while αd = 1 indicates strong temporal dependence. A previous
version of this model allowed the hyperparameters αd and σ
2
d to vary by disease and
health board within disease, however in this case the parameters were not well iden-
tified by the data, and so a simpler prior with αd and σ
2
d only varying by disease was
implemented instead. As before, weakly informative priors were assigned to αd and
σ2d to allow their values to be mainly informed from the data, and both steps to be
updated using Gibbs sampling.
4.4 Estimation
Similarly to in Chapter 3, samples were drawn from the posterior distribution us-
ing Markov chain Monte-Carlo (McMC) simulation using both Gibbs sampling and
Metropolis steps. The McMC algorithm was written (as part of this thesis) in R (R
Core Team, 2014) and the R package Rcpp was again utilised to allow some of the
more computationally intensive steps to be written in the more efficient language,
c++ (Eddelbuettel and Franc¸ois, 2011, Eddelbuettel, 2013). To make this research
reproducible the code and data are available at
https://github.com/eilidhjack/MVST-software. The updates for the majority
of these parameters are very similar to those described in Section 3.4 and so, with
the exception of Σ, little detail is given about the updates for the model developed
here.
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4.4.1 Update for βd
A Metropolis step is used to sample βd similar to that shown in Section 3.4.1. βd =
(β1d, ..., βpd) is drawn as a single block for all 4 covariates for each disease seperately.
Each of the continuous covariates were mean centered before being added to the
model to allow for easier interpretation of the HB effects.
4.4.2 Update for φi
Each φi is drawn separately using a Metropolis step similar to that shown in Section
3.4.2. Due to indentifiability issues, each φid was mean centered by health board and
disease.
4.4.3 Update for Σ
The between disease covariance matrix, Σ, is drawn using Gibbs sampling as follows:
f(Σ|Y ,X,β,H,φ) ∝ N(0, [Q(ρ,W )⊗Σ−1]−1)Inverse-Wishart(a, I), (4.4)
∝ Inverse-Wishart(a˜,B),
where,
a˜ = a+ n,
B = I + φQ(ρ,W )φ>
4.4.4 Update for ρ
Finally, the spatial correlation parameter, ρ, is drawn using a Metropolis step similar
to that described in Section 3.4.4.
4.4.5 Update for Hhtd
A Metropolis step is also used to sample the vector of Hhd effects, similar to that
shown in Section 3.4.5, where Hhtd is updated separately for each health board at
81
4. Multi-disease spatio-temporal model
each time point in each disease. The HB effects were mean centered by disease due
to identifiability issues.
4.4.6 Update for σ2d and αd
Similarly to the steps described in Sections 3.4.6 and 3.4.7, σ2d and αd are drawn using
Gibbs sampling, separately for each disease.
4.5 Results
The multivariate spatio-temporal model proposed in Section 4.3 was applied to the
data for Scotland described in Section 4.2. Inference is based on a single McMC
chain with 150,000 iterations, 50,000 of which were discarded for the burn-in period.
The chain was thinned by 5 due to limitations in computer memory and to make the
samples closer to independent, and so the posterior estimates are based on 20,000
samples. Convergence was checked both by examining parameter trace plots and
Geweke diagnostics (Geweke, 1992).
4.5.1 Correlation
The posterior medians and 95% credible intervals for the spatial and temporal cor-
relation parameters are shown in Table 4.1. The posterior median estimate for the
spatial correlation parameter, ρ, is 0.432, which suggests a moderate level of spatial
correlation across Scotland for the three diseases. A separate temporal correlation
parameter αd is assigned to each disease, and the table shows similar estimates for
coronary heart disease and respiratory disease, with posterior medians of 0.870 and
0.833 respectively. Although the posterior median for cerebrovascular disease isn’t as
high (0.689), it still shows that the data contain moderate levels of temporal correla-
tion, indicating that disease risks change smoothly year on year.
The covariance matrix Σ represents the conditional covariance between the dis-
ease specific random effects given the random effects at the remaining areas, and thus
can be used to give a measure of the correlation between the residual (after covari-
ate adjustment) risk surfaces between the two diseases. For example, the posterior
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Table 4.1: Estimates and 95% credible intervals for spatial, temporal and between disease correlations.
Spatial Correlation Posterior Median 95% CI
ρ 0.432 (0.360, 0.512)
Temporal Correlations Posterior Median 95% CI
α - Cerebrovascular Disease 0.689 (0.562,0.799)
α - Coronary Heart Disease 0.870 (0.790,0.946)
α - Respiratory Disease 0.833 (0.720,0.940)
Between Disease Residual Risk Surface Correlations Posterior Median 95% CI
Cerebrovascular and Coronary Heart 0.498 (0.465, 0.525)
Cerebrovascular and Respiratory 0.559 (0.533, 0.578)
Coronary Heart and Respiratory 0.645 (0.633, 0.658)
residual correlation between cerebrovascular and coronary heart disease risk surfaces
is calculated as
Σ12√
(Σ11Σ22)
. (4.5)
Table 4.1 shows the posterior medians of the between disease correlations, along with
the 95% credible intervals. All pairs of diseases show moderate correlation with one
another, with the correlation between coronary heart disease and respiratory disease
being the strongest with a posterior median of 0.645, while the correlation between
coronary heart disease and cerebrovascular disease is the weakest with a posterior
median of 0.498. This justifies our use of a multivariate modelling approach which
accounts for this correlation and allows for the diseases to borrow strength from each
other.
4.5.2 Health board effects
In order to investigate whether there are health inequalities between Scotland’s 14
regional health boards within each disease and how these are changing over time
(Question 1, Section 4.1), Figure 4.6 shows the posterior medians for each health
board effect on the risk scale, θhtd = exp(Hhtd), for each disease separately, after
adjusting for the known covariates. For all diseases it can be seen that there are
health inequalities between the HBs, as there are differences between the estimated
HB posterior medians within each disease. The risk of disease is not consistent
between health boards, nor is it constant over time. The way these inequalities are
changing over time also differs between diseases. For cerebrovascular disease we see
a general decreasing trend, and after around 2007 the trends seem to level off. We
also see a narrowing of the inequality between the HBs with a difference of 0.579
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between the highest and lowest median HB risk in 2003 compared to 0.184 in 2012.
Given that the island boards (Orkney (R), Western Isles (W) and Shetland (Z)) have
significantly fewer IGs than the mainland boards, we tend to see greater variation in
risk estimates for these boards over the time period. However, even when ignoring
these boards, there is still a reduction in the inequality between HBs from 0.326 in
2003 to 0.184 in 2012.
For coronary heart disease a much stronger decreasing trend can be seen over
almost all of the HBs compared to cerebrovascular disease. We also see a narrowing
of the inequality between the HBs, with a range of medians in 2003 of 0.676 compared
to 0.354 in 2012. As with cerebrovascular disease, after removing the island boards
the range in inequality lessens, but is still present, from 0.461 in 2003 to 0.270 in
2012.
Finally, the HB effects for respiratory disease do not show the same pattern as the
previous two diseases. In general, most HB risks seem to go up over the time period,
which is consistent with what was found in the raw data in Section 4.2.1. We also
see a widening in health inequalities between the HBs for this disease, with the range
between medians increasing from 0.344 in 2003 to 0.440 in 2012. However, once the
island boards were removed the increase is almost non-existent from 0.318 in 2003 to
0.319 in 2012, suggesting no change in health inequalities for respiratory disease over
the years between the mainland HBs.
We are also interested in comparing how average HB levels and temporal trends
change between diseases within a HB (Question 2, Section 4.1). To answer this,
Figures 4.7 and 4.8 show the average HB levels and temporal trends between diseases
for all 14 HBs. The posterior medians (solid) and 95% credible intervals (dashed)
for cerebrovascular disease are shown in red, green for coronary heart disease and
blue for respiratory disease. There are some HBs whose risk for each of the three
diseases is reasonably similar over the 10 years. For example, for Fife, although at the
start of the time period, the posterior median for coronary heart disease was slightly
above the null risk of 1, by the end, all three diseases have risk estimates of less than
1. For Dumfries and Galloway, although there is more variability at the end of the
time period, the risks for all three diseases are almost always below 1 and are not
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Figure 4.6: Health board risk effects across time (θhtd = exp(Hhtd)). Posterior medians shown for all health boards.
The numbers at the top of each graph represent the range in the median HB effects for each year.
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hugely different across diseases. However, from the plots it can be seen that there are
differences in disease risk and patterns over time between the diseases for the rest of
the HBs. For example, for Lanarkshire, a decreasing trend can be seen for coronary
heart disease, and in 2003 this disease has the highest estimated risk in this HB.
However, by the end of the time period the median risk for this disease is lowest in
this HB. A decreasing trend can also be seen for cerebrovascular disease. However, for
respiratory disease an increasing trend can be seen, and conversely to coronary heart
disease the disease with the lowest risk in 2003 is respiratory disease but by the end of
the time period, this disease has the highest risk for Lanarkshire. In fact, a lot of the
HBs show this switch in disease risk from coronary heart disease having the highest
risk in 2003 to respiratory disease having the highest risk in 2012. For Western Isles,
although all three diseases show a decreasing trend, the risk for coronary heart disease
was much higher than for the other two diseases in 2003, and therefore the change in
risk for this disease over time is much higher than for respiratory and cerebrovascular
disease. Another feature of these plots is the increased variability in the estimates
for the island HBs (Orkney, Western Isles and Shetland), which can be seen by the
wider credible bands and is due to them having the smallest numbers of IGs.
4.5.3 Overall health inequalities
In order to investigate whether the overall health inequalities have changed over time
across the IGs in Scotland (and not just between health boards as in Section 4.5.2)
(Question 3, Section 4.1), Figure 4.9 shows boxplots of the posterior median disease
risk for all IGs, for each disease, from 2003-2012. Printed above each boxplot is
the interquartile range (IQR) across all IGs. For cerebrovascular disease we see a
general decrease in overall trend and health inequality, which can be seen from the
narrowing of the boxplots and the decreasing IQRs, from 0.344 in 2003 to 0.250 in
2012. Similarly, the overall risk of coronary heart disease is decreasing over time,
more quickly at the beginning of the time period and after around 2009 this decrease
shows signs of leveling off. When looking at the width of the boxplots or the IQRs
we can see a decrease in health inequality in coronary heart disease risk, from 0.440
in 2003 to 0.279 in 2012, which again is more noticeable in the period from 2003 to
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Figure 4.7: Health board risk effects across time (θhtd = exp(Hhtd)) for each disease. Posterior medians in red for
cerebrovascular, green for coronary heart and blue for respiratory disease. Black dashed line indicates risk of 1. 95%
credible intervals shown by coloured dashed lines.
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Figure 4.8: Health board risk effects across time (θhtd = exp(Hhtd)) for each disease. Posterior medians in red for
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2009, after which it levels off. Conversely, for respiratory disease, we see the opposite
effect. Not only is the overall risk increasing over time, but the inequality is getting
worse, which can be seen from the widening of the boxplots and the IQR increasing
from 0.382 in 2003 to 0.532 in 2012. Some discussion on potential explanations for
these results is given in Chapter 6, Section 6.4.
Figure 4.10 shows plots of the changes in uncertainty in disease risk for each
of the three diseases over time. The lines in red show the proportion of IGs who
have significantly higher disease risks than average (95% credible intervals that are
entirely above 1), the green lines show the proportion of IGs with significantly lower
disease risk than average (95% credible intervals that are entirely below 1) and the
blue lines show the proportion of IGs whose 95% credible intervals contain 1 and
therefore show no significant difference in risk than average. For cerebrovascular
disease, the proportion of IGs with no difference in risk remains reasonably constant
and the proportion of IGs in this category is higher for this disease compared to
the other two. This is probably due to the fact that the hospital admissions are
lower for cerebrovascular disease and therefore there is less data to estimate risk and
so the uncertainty for this disease is higher. The proportion of IGs with increased
risk decreases over time and the proportion with decreased risk increases over time
for this disease. For coronary heart disease, the proportion of areas which show no
significant difference in risk doesn’t change hugely over the 10 years. The largest
change is seen in the significantly higher and significantly lower risk areas, with the
number of areas with significantly high risk decreasing from around 0.6 in 2003 to
about 0.1 in 2012 and the number of areas with significantly low risk increasing from
around 0.1 in 2003 to 0.7 in 2012. For respiratory disease, around about 0.2 of the
IGs have no difference in risk across the whole period. Whereas, the number of IGs
with significantly lower risk decreases from about 0.6 in 2003 to 0.4 in 2012 and the
proportion of IGs with significantly higher increases. However, unlike coronary heart
disease where these lines cross-over in about the middle of the time period, it isn’t
until 2012 when there are more areas with significantly increased risk than areas with
significantly decreased risk.
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Figure 4.9: Boxplots of disease risk for cerebrovascular disease, coronary heart disease, and respiratory disease in
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Table 4.2: Relative risk estimates for a 1% increase in each covariate (not urban/rural covariate) and 95% credible
intervals for the covariates in model.
Covariate Median RR 95% CI
Cerebrovascular Disease
% 16-64 year olds claiming JSA 1.060 (1.056, 1.065)
Log % Asian 0.998 (0.985, 1.011)
Log % Black 1.008 (1.002, 1.015)
Rural area 0.977 (0.949, 1.006)
Coronary Heart Disease
% 16-64 year olds claiming JSA 1.065 (1.059, 1.070)
Log % Asian 0.965 (0.951, 0.980)
Log % Black 1.001 (0.995, 1.008)
Rural area 0.953 (0.924, 0.983)
Respiratory Disease
% 16-64 year olds claiming JSA 1.105 (1.098, 1.112)
Log % Asian 0.985 (0.968, 1.001)
Log % Black 0.992 (0.985, 1.000)
Rural area 0.997 (0.966, 1.033)
4.5.4 Covariate effects
In order to assess the impact that covariates have on risk and how this changes over
disease (Question 4, Section 4.1), Table 4.2 shows the point estimates (posterior me-
dians) and 95% credible intervals on the relative risk (RR) scale. For cerebrovascular
disease the median RR for % 16-64 year olds claiming job seekers allowance is around
1.060 for a 1% increase, so the risk of cerebrovascular disease in an IG increases by
6.0% as the % claiming JSA increases by 1%. The effect of this covariate for coronary
heart disease is similar to its effect for cerebrovascular disease, with a 1% increase
corresponding to an increase in coronary heart disease risk of around 6.5%. However,
the effect of this covariate for respiratory disease is much larger, with a 1% increase
giving an increase in respiratory disease risk of around 10.5%. This could be due to
the fact that smoking is one of the main causes of respiratory disease, with nearly 8
out of 10 chronic obstructive pulmonary disease (one of the most common respiratory
diseases) deaths deemed to be a result of smoking (Centers for Disease Control and
Prevention, 2014) and deprived areas showing higher levels of smoking compared to
aﬄuent areas (NHS Scotland, 2003a).
The covariate log(% of population of Asian ethnicity) showed no evidence of a
relationship with cerebrovascular or respiratory disease risk. However for coronary
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heart disease, the median RR estimate for log(% of population of Asian ethnicity) is
0.965 and the 95% credible interval is entirely less than 1, suggesting that there may
be a very small decrease in coronary heart disease risk as this covariate increases.
This corresponds to the results found in Chapter 3, Section 3.5.5.
Neither coronary heart disease nor respiratory disease show any evidence of a re-
lationship between disease risk and log(% of population of Black ethnicity). However,
log(% of population of Black ethnicity) was found to have a small detrimental impact
of cerebrovascular disease risk, with risk increasing by 0.8% as log(% of population of
Black ethnicity) increased by 1%. This is line with findings that people of black origin
are at higher risk of stroke compared to white people (Stroke Association, 2016).
Finally, there is no evidence that living in a rural or urban area made any difference
to the risk of cerebrovascular or respiratory disease, but for coronary heart disease
the risk associated with urban areas compared with rural areas is 1
0.953
= 1.049, i.e.
there is an estimated increased risk of coronary heart disease of 4.9% when living
in an urban area compared with a rural area. Again, this is in line with the results
found in Chapter 3, Section 3.5.5.
In order to assess the sensitivity of the results from this model to the choice of
covariates, the model was also run with no covariates and the results in terms of
risk estimates were practically identical. Some comparative figures and tables can be
found in Appendix B, Section B.2.
4.5.5 Top IG risks
It was of interest to identify which IGs showed the highest risk for each disease, and
hence if there were any which exhibited high risk for more than one disease. Table
4.3 shows the IGs with the top five highest risk estimates for each disease at the start
of the time period (2003) and at the end (2012). Firstly, when comparing the IGs in
2003 to 2012, within disease, we notice that there are some IGs who make the top
five in both these years. For example, for coronary heart disease three of the IGs
with the highest risk in 2003 appear in the 2012 list, all three of which belong to the
Greater Glasgow and Clyde (G) HB. For respiratory disease, two IGs remain in the
top five for both years, again both of which belong to Greater Glasgow and Clyde.
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Finally, all five IGs for cerebrovascular disease remain the same over the time period
and all of these top five IGs belong to Greater Glasgow and Clyde. This tells us that
the IGs which are at most risk of these diseases remains reasonably consistent over
the time period.
When we compare the IGs across the diseases we also notice some similarities. For
example, IG Paisley Ferguslie which is in Renfrewshire not only appears in the top five
highest risks for all diseases in both years, but actually comes out on top for coronary
heart disease and respiratory disease and is second highest for cerebrovascular disease
in both years. IG Easterhouse South (full name: North Barlanark and Easterhouse
South) in Greater Glasgow and Clyde appears in the top five for coronary heart
disease and cerebrovascular disease for both years. Finally, Drumchapel North in
Greater Glasgow and Clyde appears for respiratory disease in 2012 as well as for
cerebrovascular disease in both years. It should also be noticed that 24 of the 30 IGs
that appear in Table 4.3 are IGs that belong to the health board Greater Glasgow
and Clyde. This highlights the extent of the deprivation, which leads to this elevated
disease risk, still experienced in some areas of the Greater Glasgow and Clyde HB.
These areas which have extremely high risk for two or all three diseases highlight
the extent of the health inequality experienced in these areas. Ultimately this means
that for the people who live in these places, the risk of hospitilisation from any one
of these three diseases is much higher than average.
4.5.6 Model comparison
In order to compare our model to an existing model in the literature we decided to
fit the model proposed by Quick et al. (2017b) to our data. Similar to our model
this model was designed for multivariate spatio-temporal data, however unlike our
model where the spatial component and temporal component are built separately,
this model allows for spatio-temporal dependency in the data using a single set of
random effects. The model is as follows:
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Table 4.3: Posterior medians and 95% credible intervals for the top 5 IGs with the highest risk for the years 2003
and 2012 for each disease. The IGs which appear for more than one disease appear in colour.
IG Name HB Median Risk 95% CI
Cerebrovascular Disease (2003)
Easterhouse South G 2.385 (2.092,2.717)
Paisley Ferguslie G 2.226 (1.938,2.544)
Parkhead West G 2.064 (1.864,2.291)
Drumchapel North G 2.060 (1.755,2.410)
Parkhead North G 2.011 (1.810,2.231)
Cerebrovascular Disease (2012)
Easterhouse South G 1.910 (1.677,2.178)
Paisley Ferguslie G 1.781 (1.554,2.043)
Parkhead West G 1.654 (1.492,1.837)
Drumchapel North G 1.650 (1.405,1.934)
Parkhead North G 1.612 (1.451,1.789)
Coronary Heart Disease (2003)
Paisley Ferguslie G 2.724 (2.454,3.024)
Lower Bow & Larkfield G 2.498 (2.296,2.709)
Easterhouse South G 2.435 (2.181,2.713)
Garthamlock G 2.267 (2.025,2.521)
Braeside G 2.256 (2.058,2.471)
Coronary Heart Disease (2012)
Paisley Ferguslie G 1.665 (1.497,1.849)
Inverness Merkinch H 1.536 (1.355,1.732)
Lower Bow & Larkfield G 1.526 (1.403,1.659)
Braehead A 1.510 (1.371,1.665)
Easterhouse South G 1.489 (1.331,1.661)
Respiratory Disease (2003)
Paisley Ferguslie G 1.955 (1.843,2.073)
Viewpark L 1.848 (1.751,1.950)
Heathryfold N 1.820 (1.713,1.930)
Drumry East G 1.794 (1.677,1.918)
Greendykes S 1.787 (1.667,1.913)
Respiratory Disease (2012)
Paisley Ferguslie G 2.627 (2.478,2.786)
Doon Valley South A 2.507 (2.357,2.665)
Drumry East G 2.412 (2.254,2.578)
Drumry West G 2.394 (2.246,2.550)
Drumchapel North G 2.327 (2.171,2.494)
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Yitd ∼ Poisson(eitdθitd),
ln(θitd) = x
>
i βd + Zitd + φitd, (4.6)
where Zitd is a spatio-temporal random effect which also accounts for between disease
correlation, and φitd ∼ N(0, τ 2d ). More detail can be found in Chapter 2, Section
2.8.2. The results from this model were broadly similar to ours and can be found
in Appendix B, Section B.3. Due to the added complexity of the model proposed
by Quick et al. (2017b) and therefore the large number of extra parameters (pd of
11,294 compared to 3,045 for our model) the computational time was far greater than
for ours. Given one of our main aims was quantifying health board inequalities, our
model was more appropriate in this context.
4.6 Discussion
In this chapter a multivariate spatio-temporal model was proposed to estimate health
inequalities in Scotland and how they have changed over time. The model included
separate covariate effects for each disease, disease specific spatial effects and disease
and health board specific temporal trends. The model was then applied to yearly
hospital admissions data at the intermediate geography level for three of Scotland’s
biggest killers, cerebrovascular disease, coronary heart disease and respiratory disease
for the period of 2003 - 2012.
The main results of this study are that, overall there has been a decrease in risk for
cerebrovascular and coronary heart disease across the HBs, but this is accompanied by
an increase for respiratory disease. We also found that even after the covariate effects
have been removed, there still exist inequalities in disease risk between the health
boards for all three diseases. These inequalities change over time and, overall they
appear to be narrowing for cerebrovascular disease and coronary heart disease with a
reduction in the range of the median HB risks, ignoring the island HBs, between the
first and last time points of 0.142 and 0.191 for each disease respectively. However,
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these inequalities show no change for respiratory disease with the difference between
ranges at the start and end of the time period being only 0.001.
Overall, across the IGs in Scotland we found that health inequalities still exist
to quite a considerable extent, and although there has been a narrowing for cere-
brovascular and coronary heart disease, the inequalities in respiratory disease appear
to be getting worse over the time period studied here. Clearly, the increase in risk
of respiratory disease observed is not occurring uniformly across all IGs. Instead,
risk is increasing at a higher rate for areas which were already exhibiting elevated
levels of risk in 2003, which is driving the increase in the health inequality for this
disease. For example, in 2003 the estimated risk for Langholm and Canonbie (lowest
risk IG) was 0.302 which increased to 0.307 in 2012. In comparison, the estimated
risk in 2003 for Paisley Ferguslie (highest risk IG) was 1.955 which increased to 2.627
in 2012. Therefore, in both the temporal HB trends and the overall risks estimates,
the results for cerebrovascular disease and coronary heart disease show improvements
both in the average risk of disease and in the health inequalities within disease, since
we have shown both to be decreasing. However, the results are not as positive for
respiratory disease, with increased risk over time, no change in inequality between
the HB effects and an increase in inequality across all of the IGs in Scotland.
A concerning feature of our results was the large number of outliers with high
risk estimates in Figure 4.9, and that there were some IGs who showed extremely
high risks of disease for more than one disease as shown in Table 4.3. This further
highlights the huge problem that Scotland faces in their inequality in overall health
and that more needs to be done to target areas which are experiencing much higher
risks of disease than the rest of Scotland.
A common problem in areal unit data of this type is that often there are changes
to boundaries which occur during the time period for which data are available. For
example, in 2014 The Scottish Government released a redrawn version of the inter-
mediate geography boundaries and there are several data sets publicly available for
which the time period overlaps this boundary change. Using data from before and
after this change would lead to incomparable inference due to spatial misalignment
in the data which would have to be dealt with. Therefore, in Chapter 5 we will
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overcome this issue by utilising a common latent spatial grid scale and use a multiple
imputation approach to estimate the data on this scale. Another area for future work
could be to consider a clustering-based modelling approach to identify areas exhibit-
ing elevated disease risks and investigate if these change over time and if there are
common high risk clusters across the three diseases.
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Spatio-temporal modelling of
respiratory disease risk with
changing spatial boundaries
5.1 Introduction
It is not uncommon for the boundaries associated with areal unit data to change over
the time period for which data are available. There are numerous reasons why such
changes may take place, most commonly due to population change over time which
reduces the usefulness of the original areal units. After the 2011 population census,
the Scottish Government decided to redraw the boundaries of the data zones which
are the key geography for small area statistics in Scotland, and are used to create the
intermediate geographies which have been used so far in this thesis. The redrawn data
zones were released in 2014 along with new boundaries for intermediate geographies.
A map showing the differences in the boundaries between the old IGs (2001) and the
new IGs (2011) is shown in Figure 5.1. Statistically, this poses a challenge since using
data from before and after this change would lead to non-comparable inference due
to spatial misalignment of the IG data. This chapter aims to address this problem
by using a multiple imputation approach to undertake inference on a common grid
for both sets of IGs, thus producing comparable inference over time. Here we adopt
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Figure 5.1: Map of 2001 IG boundaries (black) and 2011 IG boundaries (white dashed).
a common regular grid for inference, so that: (a) the results are comparable across
both sets of IG boundaries over time; and (b) the results attempt to overcome the
modifiable areal unit problem and each grid square has the same sized spatial support.
This regular grid approach has been used by Li et al. (2012a) for these reasons, and
is thus the approach I adopt here. An alternative would have been an adaptive grid,
where grid square sizes varied according to population density, with larger squares
in less populated regions. However, this violates point (b) above, and there are also
more choices to be made, as one has to choose which size each square has, rather than
just a common grid square size. A further alternative would have been to model data
on the intersections between both sets of boundaries, but this again violates point
(b) above and would lead to some areas being exceedingly small as the IG areas in
places are almost identical. The regular grid approach will then be applied to data
containing hospital admissions for respiratory disease for the years 2006 - 2016 for
the health board Greater Glasgow and Clyde, where the data from 2013-2016 are
reported on the redrawn IGs. We then aim to answer the following questions:
1. How has the risk of respiratory disease changed in Greater Glasgow and Clyde
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from 2006 -2016?
2. How are health inequalities changing over time in Greater Glasgow and Clyde
for respiratory disease risk?
We will present the results from our study and answer these questions of interest
in Section 5.5. However, first the data and details on how to compute the grid level
expected values are presented in Section 5.2. Section 5.3 gives detail on both of the
proposed multiple imputation approaches as well as the modelling approach applied
to the imputed grid data. Section 5.4 provides detail on a simulation study conducted
to determine how each multiple imputation approach performs. Finally, Section 5.6
provides a discussion on the conclusions drawn from this study and possible ways in
which it could be developed in the future.
5.2 Data
The study region is the Greater Glasgow and Clyde health board, which is the largest
of the 14 health boards in Scotland and contains Scotland’s largest city, Glasgow. The
disease data are yearly counts of the numbers of hospital admissions for respiratory
disease for the years 2006 to 2016 in each IG, where the boundaries for the years 2006
- 2012 follow the 2001 IG codes and the boundaries for 2013-2016 follow the 2011 IG
codes. Thus let Akt denote the kth IG in year t, where kt = 1, ..., nt so that there are
the same set of nt = 254 IGs for t = 1, ..., 7, (2001) and nt = 257 IGs for t = 8, ..., 11,
(2011). The disease counts are defined as Yt(Akt), where t = 1, ..., 11 denotes the
time periods and kt = 1, ..., nt denotes IG. For each year and IG, Yt(Akt) are the
number of admissions to non-psychiatric/non-obstetric hospitals in Scotland with a
main diagnosis of respiratory disease in IG Akt in year t, which is defined using the
International Classification of Diseases Volume 10 (ICD10) codes (J00:J99, R09.1).
As well as the disease counts, our data also contains the expected number of cases
collectively for each area, et(Akt), which were computed using indirect standardisa-
tion. However, given that we are interested in inference on a common grid rather
than on the original IGs, these need to be computed on the grid rather than at IG
level.
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First the common grid which will be used to make inference on is defined. A lattice
of cells, H = {H1, ...,HM} where M = 4807, of size 500m × 500m, i.e. 0.25km2,
which covers the entire study region was produced. To assess the sensitivity of grid
cell size initial research was conducted to compare 500m and 1000m grid squares.
There was very little difference in the results and so the 500m grid was chosen as
it leads to less granular risk surfaces. Figure 5.2 shows the grid with the 2001 IG
boundaries on the top and the 2011 IG boundaries on the bottom. From this it can be
seen that although the grid remains constant across the two regions, the boundaries
within the regions are not. This illustrates the importance of modelling our data on
the common spatial grid rather than the original IGs to obtain temporally comparable
inference.
Performing inference on the new grid scale poses several challenges which need to
be addressed. Firstly, the areal units Akt are designed to have non-zero populations
and hence the IGs located in the city centre are much smaller than the IGs which are
more rurally located. However, since all the grid squares are the same size, there will
be some which have a population of zero since they will be areas of fields/mountains
etc. where no one lives. We therefore remove these grid squares from our modelling,
since it does not make sense to estimate disease risk in areas with no people. Inference
is then undertaken on G = {G1, ...,Gm} ⊂ H, where m < M , defined by G =
{Hi|p(Hi) > 0}, the set of grid squares with a non-zero population. Figure 5.3 shows
a map of the 2001 IG boundaries with this subsetted grid on top.
Another issue is that along the boundary of the study region, the grid squares
cover areas which do not belong to the health board Greater Glasgow and Clyde.
Care then needs to be taken when assigning population values to each grid square
depending on what the area outwith the study region comprises of. Here a(Gi) is the
area of grid Gi and a(Akt∩Gi) is the area of the intersection between grid Gi and areal
unit Akt . Also, p(Gi) is the population of grid Gi. This was obtained for 1km
2 grids
from Reis et al. (2015) and these were converted into 0.25km2 gridded populations to
match the common grid being used for this study. This was done by assigning 1/4 of
the population from each 1km2 grid to each 0.25km2 grid within it. Finally, p(Gi|At)
is the new adjusted population in grid Gi based on our study region. We propose the
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2001 IGs
2011 IGs
Figure 5.2: Common grid overlaid on the 2001 (top) and 2011 (bottom) IG regions.
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2001
Figure 5.3: Adjusted grid overlaid on the 2001 IG regions.
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following:
1. If the area in a grid square but outwith the study region is uninhabited (e.g a
body of water) then we assign the entire population of that grid to our study
region, i.e. p(Gi|At) = p(Gi).
2. If the area in a grid square but outwith the study region belongs to a bordering
health board, then only a proportion of the population of that grid is assigned
to the study region based on the proportion of area in the grid square that is
comprised by our study region. That is p(Gi|At) = bp(Gi)
∑nt
kt=1
a(Akt∩Gi)
a(Gi)
e, where∑nt
kt=1
a(Akt∩Gi)
a(Gi)
is the proportion of the grid square in the study region, and b·e
denotes rounding to the nearest integer.
5.2.1 Estimating grid level expected values
To allocate the expected values at IG level, et(Akt), to the common grids, et(Gi), it is
clear that the total number of expected counts must be preserved, i.e.
∑nt
kt=1
et(Akt) =∑m
i=1 et(Gi). Letting et(Akt ∩ Gi) be the expected number of disease counts in the
intersection of areal unit Akt and grid Gi, then it also follows that
et(Gi) =
∑nt
kt=1
et(Akt ∩ Gi). Assuming then that the expected counts are distributed
proportionally to the population size, we have:
et(Akt ∩ Gi) =
p(Akt ∩ Gi)∑m
j=1 p(Akt ∩ Gj)
et(Akt), (5.1)
where p(Akt ∩Gj) is the population in the intersection between grid Gi and areal unit
Akt and p(Akt ∩Gi)/
∑m
j=1 p(Akt ∩Gj) is the proportion of the population of area Akt
located in grid Gi. This quantity is unknown, however we estimate it using
p(Akt ∩ Gi) =
a(Akt ∩ Gi)∑nt
rt=1
a(Art ∩ Gi)
p(Gi|At), (5.2)
where a(Akt ∩ Gi)/
∑nt
rt=1
a(Art ∩ Gi) is the proportion of geographical area in grid
Gi that is taken up by areal unit Akt and p(Gi|At) is the population of grid square i.
This assumes that population density is constant across a grid square. For illustrative
purposes, Figure 5.4 shows a simple 3×3 grid containing 4 areas. The expected counts
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Figure 5.4: 3× 3 grid containing 4 areas.
for grid number 2 is calculated as follows:
et(G2) =
p(G2|At)a(A1t ∩ G2)/
∑nt
rt=1
a(Art ∩ G2)∑m
j=1{p(Gj|At)a(A1t ∩ Gj)/
∑nt
rt=1
a(Art ∩ Gj)}
et(A1t)
+
p(G2|At)a(A2t ∩ G2)/
∑nt
rt=1
a(Art ∩ G2)∑m
j=1{p(Gj|At)a(A2t ∩ Gj)/
∑nt
rt=1
a(Art ∩ Gj)}et(A2t), (5.3)
with the remaining terms in the sum not required as their intersection areas are
empty.
5.2.2 Exploratory Analysis
Figure 5.5 shows boxplots of the SIR for respiratory disease admissions in IGs in
Greater Glasgow and Clyde from 2006 to 2016. Given that one of the goals of
this analysis is to investigate temporal trends in respiratory disease risk, the rates
for the year 2006/07 were used to calculate the expected values for all years. An
increasing trend in respiratory disease risk can be seen over the time period. In 2006
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Figure 5.5: Boxplots of the standardised incidence ratio (SIR) for respiratory disease admissions for IGs in Greater
Glasgow and Clyde from 2006 to 2016 by year. Years with 2001 boundaries shaded in grey. Years with 2011 boundaries
shaded in green.
the median SIR is 1.005, whereas in 2016 this increases to 1.374. There also seems
to be a widening in the width of the boxplots suggesting that the overall inequality
in respiratory disease risk may be increasing over time. In Chapter 4 an increasing
trend from 2003-2012 was found in respiratory disease, from this more recent data it
is clear that the trend is respiratory disease risk continues to increase.
In order to assess the presence of spatial variation in the data, and how this
has changed over the time period, Figure 5.6 shows the SIRs across IGs in Greater
Glasgow and Clyde in 2006, 2010, 2013 and 2016. Again the increasing trend over
time can be seen as the shading gets darker from 2006 to 2016. It can also be seen
that in all 4 maps there are common areas with darker shading, indicating higher risk
of respiratory disease risk, which correspond to more deprived areas of Glasgow such
as the East End and Clydebank. Another notable aspect of these maps is that in
areas which have higher risk of disease to begin with, it appears that the risk seems to
increase at a higher rate compared to areas with low risk over the time period. This
suggests that the increase in risk of respiratory disease may be more rapid for these
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areas which reinforces the potential increase in health inequality which was noted in
Figure 5.5.
5.3 Methodology
The following section outlines the methodology used to estimate Yt(Gi) using two
different multiple imputation approaches. Detail on the spatio-temporal model which
is then fitted to the grid-level estimates is also outlined.
5.3.1 Multiple Imputation Approaches
We discuss two possible multiple imputation approaches for this type of data for esti-
mating the grid level disease counts, Yt(Gi), and this general approach is implemented
as follows. Firstly, it is clearly true that
Yt(Gi) =
nt∑
kt=1
Yt(Akt ∩ Gi). (5.4)
To estimate Yt(Akt ∩ Gi), the disease counts from each areal unit Yt(Akt) can be
partitioned into the m grid square intersections Yt(Akt ∩ G1), ..., Yt(Akt ∩ Gm) using a
multinomial sampling step such as:
[Yt(Akt ∩ G1), ..., Yt(Akt ∩ Gm)]∼Multinomial(n = Yt(Akt)|ωkt1, ..., ωktm). (5.5)
Here the weights ωkti are the probability that a disease case in area Akt is assigned to
the intersection (Akt ∩ Gi). The specification of the weights, ωkti, will likely depend
on two quantities. Firstly, the proportion of the area of Akt that is comprised of the
intersection (Akt ∩ Gi), i.e.
ωkti ∝
a(Akt ∩ Gi)∑m
j=1 a(Akt ∩ Gj)
. (5.6)
This is important since the disease counts should be allocated based on the relative
size of the area of intersection between (Akt ∩Gi) compared to the other grid squares
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Figure 5.6: Spatial SIR maps for respiratory disease for the years 2006, 2010, 2013, 2016.
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areas of intersection. Secondly, the weights should depend on the number of disease
cases we would expect to observe in grid square Gi, i.e.:
ωkti ∝ et(Gi)θt(Gi), (5.7)
where et(Gi) is calculated as in Section 5.2.1. This allows the population density in
each grid square to be factored in via et(Gi), as well as the estimated risk for each
grid, θt(Gi).
However, since θt(Gi) is unknown, this quantity must be estimated before this
method can be implemented. An estimate of disease risk at the areal unit level can be
easily calculated using the standardised incidence ratio, SIRt(Akt) = Yt(Akt)/et(Akt).
We therefore propose using geostatistical modelling techniques in order to predict the
SIR at the grid level from the areal unit level SIRt(Akt), which can then be used as
our grid level estimate of risk, θt(Gi). To achieve this the spatial location of each
IG, Akt , is represented by its centroid skt for kt = 1, ..., nt and similarly the spatial
location of each grid square, Gi, is represented by its centroid ti for i = 1, ...,m. We
then use the following model, assuming that the true risk surface θt(Gi) is spatially
smooth:
Z∼N(µ1,Σ(λ)), (5.8)
where Z = (ln(SIR(A1t)), ..., ln(SIR(Ant))) is the vector of log SIR values at the nt
areal units in year t, 1 is a vector of 1s, and µ is the overall mean. The log scale is used
as the SIR is non-negative and skewed to the right, and all predictions are exponen-
tiated back to the original scale. Since spatial misalignment is the issue in the data
it was decided to Krige separately each year. This avoids any additional smoothing
over time when Kriging before estimating the temporal trend via the spatio-temporal
modelling. The spatial autocorrelation in the data is estimated via the covariance
matrix Σ(λ), where λ = (σ2, τ 2, φ) represent the partial sill, nugget and range pa-
rameters. The exponential covariance function is used and the model is fitted using
the geoR package in R (Ribeiro Jr and Diggle, 2001). I chose the exponential func-
tion as it is the most commonly used one in geostatistical applications, and having
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considered other options (e.g. Gaussian, spherical, etc) the estimated Kriged surfaces
did not change. Within geoR we first computed the binned empirical semi-variogram
(using the variog() function), which gives initial partial sill and range parameter
estimates. These estimates were then used as starting points for those parameters
when fitting the geostatistical model given by 5.8. We then use Kriging to predict
the grid level risks, θt(Gi), via the equations described in Chapter 2 Section 2.4. The
resulting predictions, θˆt(Gi), can be used to calculate the multinomial weights using:
ωkti =
et(Gi)θˆt(Gi)
a(Akt∩Gi)∑nt
rt=1
a(Art∩Gi)∑m
j=1{et(Gj)θˆt(Gj) a(Akt∩Gj)∑nt
rt=1
a(Art∩Gj)
}
, (5.9)
which combines the two weighting elements outlined in 5.6 and 5.7. These weights
were used in the multinomial imputation step described in (5.5) to estimate Yt(Gi)
for each grid square Gi. However, the imputation sampling is subject to large sam-
pling variability and to reduce this we propose drawing P realisations of the data,
Yˆt
(p)
(G) = (Yˆ
(p)
t (G1), ..., Yˆ
(p)
t (Gm)) for p = 1, ..., P , and then comparing two ap-
proaches of combining these data sets. Note that although this method technically
uses the data twice, once to estimate θˆt(Gi) via Kriging (5.8) and then again in the
multinomial imputation step (5.5), these data Yt(Ak) are never used in the modelling.
Instead the estimated grid level data Yt(Gi) are modelled and hence it could be viewed
as using the areal level data in one operation to allow for the grid level data to be
estimated.
5.3.2 Approach 1: Data averaging
In the first approach the mean is taken over the P realisations as follows:
Yˆt(Akt ∩ Gi) = b
1
P
P∑
j=1
{Yˆ (j)t (Akt ∩ Gi)}e, (5.10)
where rounding to the nearest integer is undertaken if required. With this ap-
proach the overall number of disease cases is not maintained, i.e.
∑T
t=1
∑m
i=1 Yˆt(Gi) 6=∑T
t=1
∑nt
kt=1
Yt(Akt) but the differences were not large. The mean was preferred to the
median for averaging as it produced more accurate results, in terms of
∑T
t=1
∑m
i=1 Yˆt(Gi) ≈
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∑T
t=1
∑nt
kt=1
Yt(Akt). This method therefore produces one final set of estimated grid
level disease counts Yˆ (G) which is then used to fit a spatio-temporal model.
5.3.3 Approach 2: Posterior risk averaging
The second approach involves fitting a separate spatio-temporal model to each Yˆ (p)(G)
and then combining the estimates from each model by combining the samples from
the posterior distributions for each parameter and using this to calculate any quan-
tities needed when producing model results. For example, the posterior distribution
for θt(Gi) is:
f(θt(Gi)|Yˆ ) = {f(θt(Gi)|Yˆ (1)), ..., f(θt(Gi)|Yˆ (P ))}. (5.11)
This will now have P times as many samples as each individual model before the
posterior distributions have been combined. Any quantities that need to be calculated
can be done so from f(θt(Gi)|Yˆ ) in the usual way.
5.3.4 Spatio-temporal model
Since the overarching aim of this thesis is to quantify how health inequalities are
changing over time, a spatio-temporal model which allows for an overall temporal
trend, and separate spatial surfaces for each time period was deemed to be appro-
priate. This allows for a separate variance parameter at each time period which will
allow for the comparison of health inequalities over time. A generalisation of the
model proposed by Napier et al. (2016) was fitted and is of the form:
Yˆt(Gi) ∼ Poisson[et(Gi)θt(Gi)] i = 1, ...,m, t = 1, ..., T, (5.12)
ln[θt(Gi)] = β0 + φt(Gi) + δt,
where θt(Gi) is the grid level risk of disease for the model. The overall temporal
trend is represented by δ = (δ1, ..., δT ) and this is augmented by a separate spatial
surface at each time period, φt(G) = (φt(G1), ..., φt(Gm)). Spatial autocorrelation
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is induced via an m × m neighbourhood matrix W . Since we have removed grid
squares with a population of zero we are unable to specify neighbours based on if two
areas share a common border, like we have in previous chapters, since some areas
will have no neighbours under this specification, which can be seen in Figure 5.3.
Instead we use the k-nearest neighbours specification with k=4. The value of 4 was
chosen since this would have been the number of neighbours most grids would have
had if using the sharing a common border specification (assuming rook adjacency).
However, one issue with this is that the resulting W matrix is not symmetric since
it could be that wij = 1 and wji = 0 under this specification. We therefore force W
to be symmetric by setting wij = wji = max{wij, wji} to overcome this. Similarly to
previous chapters, we model the spatial random effects using the Leroux CAR prior
(Leroux et al., 2000) given by
φt(Gi)|φt(G−i)∼N

ρS
m∑
j=1
wijφt(Gj)
ρS
m∑
j=1
wij + (1− ρS)
,
τ 2t
ρS
m∑
j=1
wij + (1− ρS)
 , (5.13)
τ 2t ∼ Inverse-Gamma(1, 0.01),
ρS ∼ Unif(0, 1),
where φt(G−i) = (φt(G1), ..., φt(G(i−1)), φt(G(i+1)), ..., φt(Gm)). The spatial dependence
parameter ρS is common to all time points but the variance parameter τ
2
t is allowed
to vary over time. This is beneficial since the changes in variance, and therefore in
inequality, are of direct interest here. The overall temporal trend δ = (δ1, ..., δT ) is
also given a Leroux CAR prior with a common temporal dependence parameter ρT
and variance parameter τ 2T :
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δt|δ−t∼N

ρT
T∑
j=1
dtjδj
ρT
T∑
j=1
dtj + (1− ρT )
,
τ 2T
ρT
T∑
j=1
dtj + (1− ρT )
 , (5.14)
τ 2T ∼ Inverse-Gamma(1, 0.01),
ρT ∼ Unif(0, 1).
Similar to the neighbour matrix W , D = (dtj) is a binary T × T temporal neigh-
bourhood, where dtj = 1 if |j − t| = 1 and dtj = 0 otherwise.
5.3.5 Estimation
In order to obtain posterior summaries of each parameter, samples were drawn from
the posterior distribution using Markov chain Monte-Carlo (McMC) simulation using
both Gibbs sampling and Metropolis steps. Since the focus of this chapter was
developing an approach for pseudo-continuous inference on a common grid rather
than the development of a novel spatio-temporal model (as in Chapter 4), the model
was fitted using the CARBayesST package(Lee et al., 2018) in R (R Core Team, 2014).
5.4 Simulation study
In order to determine which of the two imputation methods is best, a simulation
study was conducted under two different scenarios.
• Scenario 1 - increasing trend over time.
• Scenario 2 - no trend over time.
For each scenario, 100 data sets were simulated on the common grid, which were
then aggregated to areal unit level in order to be in the same form as the data in this
study as follows:
Y (Akt) =
m∑
i=1
{ a(Akt ∩ Gi)∑nt
rt=1
a(Art ∩ Gi)
Y (Gi)
}
. (5.15)
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Each of the simulated aggregated data sets were then imputed using both of the
approaches described above (see Sections 5.3.2 and 5.3.3). The bias, root mean
square error (RMSE) and 95% coverage probabilities were then calculated for the
corresponding risk estimates for each method as follows.
1. Bias
Bias[θt(Gi)] = E[θˆt(Gi)]− θt(Gi) ≈ 1
100
100∑
j=1
θˆ
(j)
t (Gi)− θt(Gi). (5.16)
2. RMSE
RMSE[θt(Gi)] =
√
E[{θˆt(Gi)− θt(Gi)}2] ≈
√√√√ 1
100
100∑
j=1
{θˆ(j)t (Gi)− θt(Gi)}2.
(5.17)
3. Coverage probability - The percentage of the 95% credible intervals for θt(Gi)
which contain the true value for θt(Gi).
Due to issues with memory it was decided to reduce the size of the data set to
be simulated to 8 years rather than the full 11 years (which reduces the number of
grids from 34507 to 25096), i.e. t = 1, ..., 8, corresponding to the years 2009-2016.
For each method P , the number of data realisations drawn from Equation 5.5, was
set to 20. These results are summarised below.
Firstly, the overall bias, RMSE and 95% coverage probabilities are shown in Table
5.1 averaged over both the 100 simulated data sets and over all elements (i.e. over all
grid cells m and time points T ) in each simulated data set. These results show that in
both scenarios, over all risk estimates, the posterior risk averaging approach performs
better than the data averaging approach in terms of bias, RMSE and coverage. The
bias and RMSE are closer to 0 and the coverage is closer to the nominal 0.95 levels
for this approach in both scenarios. The data averaging approach has relatively low
coverage in both scenarios, suggesting that the 95% credible intervals are too narrow.
This is probably since the data being fed into the spatio-temporal model, Yˆ (Gi), has
been estimated and is therefore already incorrect before even being modelled. Hence,
the estimation from the model is going to be poor (since it is based on an estimation
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Table 5.1: Overall bias, RMSE and coverage for all risk estimates under both scenarios.
Scenario Approach Bias RMSE Coverage
Increasing trend
Data averaging -0.01388 0.10516 0.767
Posterior risk averaging -0.00874 0.08106 0.924
No trend
Data averaging -0.01647 0.11785 0.757
Posterior risk averaging -0.01057 0.09894 0.927
of the data) and therefore the coverage is low. Whereas with the posterior risk
averaging approach, although each Yˆ (Gi) is still an estimate and therefore incorrect,
we are now combining the results from 20 difference realisations of Yˆ (Gi), and so we
are incorporating the uncertainty in the imputed values of Y (Gi) when estimating
the model parameters. Hence, the uncertainty intervals are wider and the coverage
higher.
We believe that the reason the posterior risk averaging approach may perfom
better in terms of bias and RMSE may be partially due to the fact that, in the model
averaging approach, the overall number of disease cases is not maintained (see Section
5.3.2 for details) and is always lower than the true number. Hence, in the grids where
these disease counts are lost the risk may not be estimated accurately.
Figures 5.7, 5.8 and 5.9 show histograms of the bias, RMSE and 95% coverage
probablities for each risk estimate averaged over the 100 simulated data sets for each
approach. From Figure 5.7, it can be seen that in both scenarios, the histogram
for the posterior risk averaging approach has a higher frequency of estimates with
a bias close to 0. This approach also appears to be more symmetrical around 0
than the data averaging approach. The data averaging approach shows slightly more
spread indicating that, on average, posterior risk averaging gives slightly less biased
results. From Figure 5.8, again there appear to be slighty more estimates with an
RMSE closer to 0 for the posterior risk averaging approach than the data averaging
approach, although this is very marginal. This backs up the results from Table 5.1
that the posterior risk averaging approach is less biased and produces less varied
results. Finally, from Figure 5.9 it is clear to see that the 95% coverage probabilities
for each risk estimate using posterior risk averaging are, on average, higher than
those for data averaging. This suggests that under posterior risk averaging, the
95% credible intervals are much closer to the correct width than they are using data
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Figure 5.7: Bias for risk estimates over 100 simulated data sets for each imputation approach and each simulation
scenario.
averaging. In all three figures it can be seen that in both scenarios and methods,
for some estimates the modelling approach does not perform very well. This can be
seen by the small number of outliers in each of the histograms. However, for the vast
majority of risk estimates, on average, the posterior risk averaging approach and the
following spatio-temporal modelling performs well and provides accurate results.
5.5 Results
The posterior risk averaging method proposed in Section 5.3.3 was applied to the
data for Greater Glasgow and Clyde described in Section 5.2 with P , the number
of data sets drawn from Equation 5.5, equal to 20. The spatio-temporal model
described in Section 5.3.4, proposed by Napier et al. (2016), was then applied to
each of P sets of imputed grid data. For each model a single McMC chain was
run for 250,000 iterations, 150,000 of which were discarded for the burn-in period.
Each chain was thinned by 50 due to limitations in computer memory and to reduce
autocorrelation of the Markov chain, hence the posterior chains from each model
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Figure 5.8: RMSE for risk estimates over 100 simulated data sets for each imputation approach and each simulation
scenario.
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Figure 5.9: 95% coverage probabilities over 100 simulated data sets for risk estimates for each imputation approach
and each simulation scenario.
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contain 2000 nearly uncorrelated samples. These are then combined over the P
models to calculate posterior estimates for each parameter which are based on 40,000
samples.
Of the 34507 data points on the grid scale, 15892 were estimated to be 0 (46.1%),
hence the model is expected to estimate parameters with many data points providing
very little information. In order to increase the information provided to the model
the spatial dependence parameter, ρS, and the temporal dependence parameter, ρT ,
were set to be 1, thus forcing a spatio-temporally smooth surface. Strong temporal
smoothness is expected because the population in a grid square is largely the same
set of people each year, hence their risk of hospitalisation will be unlikely to change
rapidly from one year to the next. Similarly, strong spatial correlation is expected as
the grid squares are small units of 500m2, and hence one would expect neighbouring
ones to have similar risks as a result of Tobler’s first law of geography which states
‘Everything is related to everything else, but near things are more related than distant
things.’ (Tobler, 1970). Furthermore, exploratory analysis of the data at the coarse
IG level shows (via Moran’s I correlation statistic) that the data contain strong
spatial correlation, hence at the smaller grid level this will also occur. To assess the
sensitivity of the results, the models were also run with ρS and ρT equal to 0.9 (which
does not violate our belief that the data contain strong spatio-temporal correlation)
and the results were very similar. Model convergence was checked both by examining
parameter trace plots and Geweke diagnostics (Geweke, 1992).
5.5.1 Spatial pattern over time
In order to investigate how the risk of respiratory disease has changed in Greater
Glasgow and Clyde from 2006 to 2016 (Question 1, Section 5.1), Figure 5.10 shows
estimated respiratory disease risks for Greater Glasgow and Clyde for the years 2006,
2010, 2013 and 2016. Looking at each map individually clearly the risk of respiratory
disease is not constant over Greater Glasgow and Clyde. Areas of high risk can be
seen in each of the 4 maps which correspond to more deprived areas of the health
board such as the East End of Glasgow and Clyde Bank. This is no surprise given
the results from the previous Chapters where areas in Greater Glasgow and Clyde
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were found to have some of the highest disease risk in Scotland. Now looking at
the pattern in risk over time it can be seen that the risk of respiratory disease is
increasing over the time period studied here. Although there seems to be a general
increase over the whole area, it is most prominent in the areas which were already
exhibiting increased risk at the start of the time period. This suggests that the rate
at which the risk of respiratory disease is increasing is higher in these areas, which
suggests that health inequalities are also increasing over this time frame.
When we compare these maps to the raw SIR maps shown in Figure 5.6 the maps
of disease risk are much smoother. This can be explained firstly, as touched on in
previous chapters, given the nature of spatial smoothing where random effects borrow
strength from their neighbours, the corresponding risk estimates tend to be smoother
and less extreme than the raw SIR values. However the most obvious reason for the
smoothness of the risk estimates from the model is that they are now estimated on a
psuedo-continuous grid rather than on the original IGs.
5.5.2 Overall health inequalities
In order to investigate how health inequalities in respiratory disease risk have changed
over time in Greater Glasgow and Clyde (Question 2, Section 5.1), Figure 5.11 shows
boxplots of the posterior median respiratory disease risk for all grids from 2006 to
2016. The years where data are collected on the new 2011 boundary IGs are shaded in
green. Firstly from this plot we see an overall increasing trend in respiratory disease
risk in Greater Glasgow and Clyde from 2006 to 2016. This is in line with what was
found in Chapter 4 and indicates that the risk has continued to increase steadily from
2012 onwards.
In order to assess how health inequalities in respiratory disease risk have changed
over time in Greater Glasgow and Clyde the variation in estimated disease risk is of
interest. This can be assessed in Figure 5.11 by either looking at the width of the
boxplots, or by examining how the interquartile range, which is printed at the top of
each boxplot in red, changes over time. From this it can be seen that overall there has
been an increase in health inequalitity over time in Greater Glasgow and Clyde. The
IQR for 2006 is 0.357 compared to 0.444 in 2016. Not only has the IQR increased
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Figure 5.10: Spatial risk maps for respiratory disease for the years 2006, 2010, 2013, 2016.
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Figure 5.11: Boxplots of disease risk for respiratory disease in grids in Greater Glasgow and Clyde from 2006 -
2016. The IQR across grids are printed in red. Outliers are those observations that lie outside 1.5(IQR).
over time but the number of outliers with high risk also seems to have increased over
time. In fact, in 2006 the grid with the highest risk of respiratory disease had an
estimate of 2.205, meaning that those living in this grid are 2.2 time more at risk of
respiratory disease than average. In 2016 this increases to 3.277, i.e. those living in
this grid are more than 3 times more at risk of respiratory disease on average. These
results are in line with what was found in Chapter 4 and show that the increase in
health inequality which was found in Figure 4.9 until 2012 has continued to increase
until 2014 where it may begin to level off slightly.
When comparing Figure 5.11 to Figure 5.5, which shows the boxplots of the raw
SIR for all IGs over the time period, several differences may be noticed. Firstly, the
median risk level in Figure 5.11 has been shifted downwards for every year. Initially
this may seem odd as the median estimated risk of respiratory disease risk should
not be significantly different from the median for the raw SIR, however we believe
there is an explanation for this. Fundamentally these two figures are not showing the
same thing, one is SIR based on the original IGs and the other shows estimated risk
122
5. Model for changing spatial boundaries
on the grids. When looking at Figure 5.6 which shows the spatial pattern of SIR it
can be seen that the areas with low values of SIR tend to be the geographically large
IGs, whereas the areas with high values of SIR are predominantly the geographically
small areas. Therefore, when the IG data is imputed onto the common grid, the
areas which exhibit high risk, which are geographically small, have fewer grids to
allocate the hospital admissions to. Compare this to the areas which exhibit low
risk and are generally larger geographically, there are now a large number of grids to
allocate a relatively small number of hospital admissions to, and so the proportion of
grids which are estimated to have low risk will be much larger than the proportion of
IGs which have low values of SIR. This will then lead to the median risk level being
lowered when moving from IGs to grids. This phenomenon could also explain the
other notable difference between Figures 5.5 and 5.11, which is the increased number
of outliers with high estimated risk. To emphasise this point, the IG in Greater
Glasgow and Clyde which is smallest geographically has an area of 0.19km2, which
is in fact smaller than the area of each grid, which is 0.25km2. Compare this to the
IG which is largest geographically, which has an area of 111.41km2. This is over 400
times larger than each grid square. Clearly then the number of grid squares which
contain a considerable number of hospital admissions will be a substantially smaller
proportion than at the IG level and so they are more likely to show up as outliers
exhibiting high risk in Figure 5.11.
5.6 Discussion
In this chapter two multiple imputation approaches were proposed to estimate data on
a common grid which allows for comparable inference over time when the boundaries
on which data are collected on change. A simulation study was conducted to compare
the two methods and the results showed than in terms of bias, RMSE and 95%
coverage the posterior risk averaging approach (see Section 5.3.3) performed better
than the data averaging approach (see Section 5.3.2). The posterior risk averaging
approach was then applied to data containing hospital admissions for respiratory
disease for the years 2006-2016 for the health board Greater Glasgow and Clyde,
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where the data from 2013-2016 are reported on the redrawn IGs. A spatio-temporal
model was then applied to the imputed data, Yˆt(Gi), to investigate how the risk of
respiratory disease has changed over time across Greater Glasgow and Clyde and how
health inequalities in risk have changed.
The main results from this chapter show that there has been an increase in risk
of respiratory disease risk in Greater Glasgow and Clyde from 2006 - 2016. This is in
line with findings from Chapter 4, however the disease risk has now been estimated
for a more recent time period, during which the boundaries of the IGs which data
are collected on were changed. This approach has therefore allowed for the modelling
of this data which would not have been possible using the data in the original IG
form. It was also found that the health inequality in respiratory disease risk has also
increased over the time period, meaning that the differences in risk between Greater
Glasgow and Clyde’s most aﬄuent and most deprived areas is getting worse. Again,
this in the line with findings from Chapter 4 and shows that health inequalities have
continued to increase from 2012 onwards.
Although the methods developed in this chapter allow for spatio-temporal mod-
elling of data over a time period that would not have been possible using the original
data, there is one clear drawback. Namely, if the Kriging of the SIR values onto
the grid is not accurate, then the data on the grid which are used in the final mod-
elling and hence the resulting inference will also not be accurate. Future work could
therefore consider a data augmentation approach which would overcome this issue by
combining the multinomial imputation step in Equation 5.5 within the McMC estima-
tion algorithm which estimates the other parameters in the model. More specifically,
the model parameters from 5.12, 5.13 and 5.14 could be estimated using McMC up-
dates based on the current value of each Yt(Gi). Then each Yt(Gi) could be updated
via data augmentation using the multiple imputation step 5.5 with the same weights
as before (5.9). Here, θˆ(Gi), would be estimated within the McMC sampler rather
than outwith the modelling as in our approach.
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Discussion and future work
This thesis focused on quantifying health inequalities across Scotland and estimating
how they are changing over time, an issue which has huge repercussions for the people
living in Scotland. There have been many studies on health inequalities in Scotland
which were discussed in Chapter 1, however much of the existing research lacks in-
depth analysis of health inequalities at the small area scale in Scotland, which is the
focus of this thesis. Such approaches assess the extent and pattern of disease risk
by partitioning the study region into a set of contiguous areal units, estimating the
disease risk for each area and then presenting these risks on a disease map. The most
common approaches are based on conditional autoregressive (CAR) models which are
introduced in Chapter 2.
6.1 Single disease model
In Chapter 3, I proposed a spatio-temporal model for quantifying health inequalities
in one disease in Scotland at a small area level using disease mapping techniques.
This model was applied to data containing hospital admissions for one of Scotland’s
biggest killers, coronary heart disease (Scotpho, 2016), for the years 2003-2012. It
was found that there are differences in coronary heart disease risk across Scotland
and that these risks are changing over time. Overall, there was a decrease in coronary
heart disease risk in Scotland over the time period. As well as seeing a decrease in risk
over time, crucially, the health inequality in risk also decreased over the time period.
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It was also of interest to identify any health inequalities in the risk of coronary heart
disease between Scotland’s 14 regional health boards and to estimate how they are
changing over time. It was found that even after adjusting for deprivation (and other
covariates), health inequalities in coronary heart disease risk still exist between the
health boards although again, these have decreased over time.
6.2 Multi-disease model
In Chapter 4 the single disease model was extended to a more realistic multivariate
disease risk model, where multiple diseases are investigated to better understand how
health inequalities have changed across Scotland over time. This chapter proposed
a novel spatio-temporal multi-disease model which was applied to data containing
two more of Scotland’s biggest killers, cerebrovascular disease and respiratory dis-
ease, alongside the coronary heart disease data. The between-disease correlation was
estimated to be moderate between all pairs of disease which justifies our use of a
multivariate modelling approach as it accounts for this correlation and allows for the
diseases to borrow strength from each other. The results showed that although there
was a decrease in risk for cerebrovascular disease and coronary heart disease overall
in Scotland, this was accompanied by an increase in risk of respiratory disease. It
was also found that across all IGs there was a decrease in health inequality for cere-
brovascular disease and coronary heart disease over the time period, although they
do still exist to a considerable extent. However, the inequalities in respiratory disease
appear to be getting worse over the time period studied here. Similar to the results
from Chapter 3, there was also still evidence of health inequalities between Scotland’s
health boards for all three diseases after covariate effects had been removed. Another
concerning feature of these results are the similarities in the IGs which appear in the
top 5 highest risk IGs at the start and end of the time period for each of the three
diseases. Several IGs were placed in the top 5 in 2002 and 2012 for more than one
disease. This shows the extent of the health inequality experienced in these areas and
highlights that more needs to be done to target areas which are experiencing much
higher risks of disease than the rest of Scotland.
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6.3 Changing boundaries over time
One issue that was identified in this thesis and is a common problem in areal unit
data of this type is a change to the boundaries during the time period for which
data are collected. In 2014, the Scottish Government released a redrawn version of
the intermediate geography boundaries. Therefore, the models which are outlined in
Chapters 3 and 4 cannot be applied to any data which spans the time period in which
this change occurs in the form that it is usually available, i.e. at IG level in Scotland.
Chapter 5 therefore proposed two multiple imputation approaches, data averaging
and posterior risk averaging (Sections 5.3.2 and 5.3.3), which address this problem
by undertaking inference on a common grid for both sets of IGs, thus producing
comparable inference over time. A simulation study was conducted to compare the
two methods and the results showed that in terms of bias, RMSE and 95% cover-
age the posterior risk averaging approach permormed better than the data averaging
approach. The posterior risk averaging approach was then applied to data contain-
ing hospital admissions for respiratory disease for the years 2006-2016 for the health
board Greater Glasgow and Clyde, where the data from 2013-2016 are reported on
the redrawn IGs. A spatio-temporal model was then applied to the imputed data
to estimate how the risk of respiratory disease has changed over time in the Greater
Glasgow and Clyde health board area and investigate any changes in health inequali-
ties over this time period as well. The results from this model showed that the risk of
respiratory disease has increased over the time period in Greater Glasgow and Clyde.
This was accompanied by an increase in health inequalities in respiratory disease risk,
indicating that the risk is increasing at a higher rate in areas whose risk was already
elevated to begin with.
6.4 Common results and discussion
In this thesis, some common themes have been identified from Chapters 3, 4 and 5.
First of all, health inequalities are improving for some diseases but not for others,
demonstrating the importance of looking at more than one disease to get an over-
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all picture of health inequalities in Scotland. In particular, it was found that the
risk, and inequalities in risk, of coronary heart disease and cerebrovascular disease
are decreasing over time across Scotland. However, the risk of respiratory disease as
well as the health inequality in that risk are increasing over time across Scotland.
Research into the prevalence of respiratory diseases in the UK by the British Lung
Foundation has shown that in 2011 approximately 67% of UK hospital admissions
from respiratory diseases were due to pneumonia, chronic obstructive pulmonary dis-
ease and acute lower respiratory infections. From these, both pneumonia, and more
so chronic obstructive pulmonary disease, have shown increasing numbers of diag-
noses over the time period 2004-2012 (The British Lung Foundation, 2013). It has
also been estimated that the number of people with a chronic obstructive pulmonary
disease diagnosis in Scotland will rise by 20% from 2011 to 2030 with a corresponding
increase in costs of £48million (McLean et al., 2016). This increase in risk of respi-
ratory disease, therefore, may be partially due to increased diagnoses, which in turn
would result in an increase in hospital admissions. The increase in respiratory disease
admissions could also be due to a reduction in competing causes for hospitalisation,
given that there has been a reduction in risk of hospitalisation for cerebrovascular
disease and coronary heart disease. Another important result is that this increase
in hospital admissions is not occurring uniformly across all IGs. Instead, IGs which
already had high risks of respiratory disease at the start of the time period are seeing
more of an increase in numbers, which is driving the increase in the health inequality
for this disease.
In Chapters 3 and 4 it was also found that these health inequalities do not just
exist at the small area level but also between Scotland’s 14 national health boards.
The extent to which these exist is concerning as ideally the health board in which a
person lives would not have an impact on their risk of disease, particularly at a large
area level such as this. However, it was found that these health inequalities between
the health boards have reduced quite significantly for cerebrovascular disease and
coronary heart disease.
There were many significant changes to the structure of the health service in
Scotland in the years before and during the time period of this data, which could help
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to explain some of the improvements observed. In 1997, Designed to care: renewing
the NHS in Scotland (Scottish Office, 1997) was published with the main aim of
phasing out the internal market, integrating services to eliminate duplication and
wasteful competition and merging 47 Scottish trusts into 28. Following the Scottish
devolution in 1999, Our national health: a plan for action, a plan for change (Scottish
Executive, 2000) stated that the health budget in Scotland was due to rise from £4.9
billion in 1999-2000 to £6.7 billion in 2003-2004 (which coincides with the start of
the time-period in Chapters 3 and 4). This considerable resource increase was to
be used to build a modernised health system and improve the health of Scotland’s
population.
In the period 2003-2006 there were several more policy changes which may have
contributed to the results found in this thesis. First of all, in 2003, Partnership for
care: Scotland’s health White Paper (NHS Scotland, 2003b) was released, which led
to the abolition of the NHS Trusts in 2004. These were absorbed into the health
boards which have been the focus of this thesis. The health boards were given single
tier responsibility for governance and accountability and health improvement was
made a priority. This policy change also led to the creation of 40 community health
partnerships (CHPs) which were the vehicle for planning and delivery of primary and
community based services (The Scottish Government, 2010). The CHPs were given
the responsibility (along with the health boards) in improving health and reducing
health inequalities and were able to work locally, not only to tackle smoking, obesity,
drug and alcohol misuse etc, but also to work with other agencies to tackle many of
the other social determinants of health.
The National Service Framework (Scottish Executive, 2005) published in 2005 set
out long-term plans for the NHS in Scotland over the next 20 years. The key message
was to look to the population of Scotland to take more responsibility for their own
health and ‘anticipate and prevent rather than react ’. Another key piece of legislation
during this time period was The Smoking, Health and Social Care (Scotland) Act
2005, which banned smoking in any enclosed public space in Scotland from 26 March
2006. The ban was described by the Chief Medical Officer, Mac Armstrong as bringing
‘far and away the most important improvement in our health in a generation’. In
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2007, Better Health, Better Care: Action Plan (The Scottish Government, 2007) was
introduced which views patients and the public as ‘partners rather than recipients of
care’. This again outlines the focus of helping the public improve their health, acting
proactively rather than reactively, particularly in disadvantaged communities. This
shift in perspective, I believe, is crucial to truly tackling the health inequalities that
still exist in Scotland.
Reducing the size of Scotland’s health inequalities has clearly been a key focus of
both the Scottish Government and NHS Scotland, with many of these policy changes
directly stating that an improvement in health inequalities as well as overall health
is of importance for Scotland’s people moving forward. This thesis quantifies these
changes, and a concerning feature of the results is the large number of outliers with
high risk estimates as illustrated in Figures 4.9 and 5.11. This further highlights the
huge problem that Scotland faces in inequality in the overall health of its population
and that more needs to be done to target areas which are experiencing much higher
risks of disease than other parts of Scotland.
6.5 Limitations and future work
There are several limitations to this work, some of which were unavoidable while
others only came to light as a result of the research undertaken. From a data per-
spective, ideally there would have been data available for a longer time period to
allow for more complex modelling of the temporal aspect to the models in Chapters
3 and 4. However, as described in Chapter 5, any data collected after 2012 could not
have been used in its original form. In Chapter 5 if possible, this approach would
have been implemented over the same study region as the previous two chapters, i.e.
over all of Scotland. However considering there were 3137 grid squares in Greater
Glasgow and Clyde alone, over 11 years this leads to 34507 data points. To do this
over all of Scotland at this scale would have been computationally infeasible and so
it was decided to apply the model to one health board only. This also means we were
unable to compare health inequalities between the health boards as has been done in
Chapters 3 and 4. Future work could consider applying this method to all of Scotland
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using a lattice of cells of a larger area. However, this would be a trade-off between
having grid cells which are large enough to cover all of Scotland without resulting in
an infeasibly large data set whilst ensuring that the grids are small enough to provide
the information needed to investigate health inequalities at the small area level, and
that the resulting data aren’t aggregated too much. For example, in areas where the
original IGs are small (e.g. in cities), a lattice of larger grid cells would lead to loss
of information as disease counts in neighbouring IGs would be merged together. A
way to overcome this could utilise an adaptive lattice with non-uniform grid cell size.
The methods developed in Chapter 5 has one main drawback in that if the im-
putation of θˆ(Gi) is not accurate, then the data, Yt(Gi) ,which the spatio-temporal
model is fitted to and hence the resulting inference will be inaccurate. Therefore,
future work could develop an approach which overcomes these issues, for example, a
data augmentation strategy which allows for Yt(Gi) to estimated within the McMC
estimation algorithm.
It may also be of value to implement these methods using a multivariate approach
similar to that proposed in Chapter 4 to allow for a better understanding of how
health inequalities have changed across Greater Glasgow and Clyde. However, as
yet, there are no freely available data over this time period for coronary heart disease
and cerebrovascular disease. Developing a data augmentation technique within the
multivariate model proposed in Chapter 4 and applying this to data for multiple
diseases when these datasets are freely available would be a worthwhile future project.
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Statistical properties
A.1 Conditional Distribution Property of a
Multivariate Gaussian Distribution
Given the joint distribution of X = (X1,X2) is,
X =
 X1
X2
 ∼ N

 µ1
µ2
 ,
 Σ11 Σ12
Σ21 Σ22

 . (A.1)
Then the conditional distribution of X1|X2 is given by
X1|X2 ∼ N(µ1 + Σ12Σ−122 (X2 − µ2),Σ11 −Σ12Σ−122 Σ21). (A.2)
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Comparison of the multivariate
model from Chapter 4 to other
models
B.1 Temporally changing beta
The results from the model which allows the regression parameters to change over
time can be found seperately for each disease in Tables B.1, B.2 and B.3. In general
these show little change in both the point estimates and the 95% credible intervals over
time and compared with the corresponding estimates from the model with temporally
static estimates (Table 4.2). In almost all cases the 95% credible intervals overlap for
all pairs of time periods.
B.2 No covariates
In order to test the sensitivity of our results to the choice of covariates, our model
was run again with no covariate effects. The results were virtually the same and some
figures are shown here for comparison. Figure B.1 shows boxplots of the disease risk
for all three diseases from the model with no covariates. When compared to Figure
4.9 in the main text, it can be seen that there is very little change. Figure B.2 in
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Table B.1: Relative risk estimates for a 1% increase in each covariate (not urban/rural covariate) and 95% credible
intervals for the covariates in a model with temporally varying regression parameters for cerebrovascular disease.
Significant results are in bold.
Covariate - Cerebrovascular Median RR 95% CI
% 16-64 year olds claiming JSA
2003 1.063 (1.054, 1.072)
2004 1.061 (1.052, 1.069)
2005 1.065 (1.057, 1.074)
2006 1.059 (1.050, 1.067)
2007 1.058 (1.049, 1.067)
2008 1.061 (1.053, 1.070)
2009 1.059 (1.051, 1.068)
2010 1.056 (1.048, 1.065)
2011 1.056 (1.047, 1.065)
2012 1.060 (1.051, 1.068)
Log % Asian
2003 1.004 (0.980, 1.029)
2004 0.990 (0.967, 1.014)
2005 1.004 (0.979, 1.027)
2006 1.015 (0.992, 1.040)
2007 0.985 (0.962, 1.009)
2008 0.993 (0.970, 1.016)
2009 1.000 (0.981, 1.029)
2010 0.995 (0.940, 0.987)
2011 0.993 (0.968, 1.017)
2012 1.018 (0.994, 1.043)
Log % Black
2003 1.005 (0.992, 1.017)
2004 1.023 (1.010, 1.036)
2005 1.014 (1.002, 1.027)
2006 1.002 (0.989, 1.014)
2007 1.017 (1.002, 1.031)
2008 1.001 (0.989, 1.013)
2009 1.008 (0.995, 1.021)
2010 1.018 (1.006, 1.031)
2011 1.009 (0.996, 1.022)
2012 0.992 (0.980, 1.004)
Rural area
2003 1.036 (0.978, 1.098)
2004 1.009 (0.954, 1.068)
2005 0.997 (0.940, 1.053)
2006 0.938 (0.888, 0.992)
2007 0.958 (0.903, 1.011)
2008 0.960 (0.910, 1.013)
2009 0.993 (0.940, 1.046)
2010 0.950 (0.902, 1.006)
2011 1.004 (0.950, 1.060)
2012 0.940 (0.887, 0.994)
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Table B.2: Relative risk estimates for a 1% increase in each covariate (not urban/rural covariate) and 95% credible
intervals for the covariates in a model with temporally varying regression parameters for coronary heart disease.
Significant results are in bold.
Covariate - Coronary Heart Disease Median RR 95% CI
% 16-64 year olds claiming JSA
2003 1.067 (1.059, 1.074)
2004 1.067 (1.060, 1.075)
2005 1.063 (1.055, 1.070)
2006 1.058 (1.050, 1.065)
2007 1.059 (1.052, 1.067)
2008 1.069 (1.061, 1.076)
2009 1.066 (1.059, 1.074)
2010 1.065 (1.057, 1.073)
2011 1.063 (1.055, 1.071)
2012 1.067 (1.061, 1.077)
Log % Asian
2003 0.944 (0.927, 0.962)
2004 0.953 (0.936, 0.971)
2005 0.932 (0.916, 0.950)
2006 0.944 (0.927, 0.962)
2007 0.961 (0.944, 0.980)
2008 0.977 (0.960, 0.998)
2009 1.002 (0.983, 1.010)
2010 0.989 (0.970, 1.009)
2011 0.974 (0.956, 0.995)
2012 0.985 (0.966, 1.007)
Log % Black
2003 1.003 (0.994, 1.013)
2004 1.003 (0.994, 1.013)
2005 0.999 (0.989, 1.008)
2006 0.996 (0.986, 1.005)
2007 1.000 (0.991, 1.010)
2008 0.997 (0.988, 1.007)
2009 1.000 (0.990, 1.009)
2010 1.006 (0.996, 1.017)
2011 1.004 (0.994, 1.015)
2012 1.012 (1.002, 1.022)
Rural area
2003 0.920 (0.881, 0.965)
2004 0.942 (0.901, 0.984)
2005 0.911 (0.871, 0.955)
2006 0.942 (0.900, 0.984)
2007 0.954 (0.913, 0.997)
2008 0.968 (0.925, 1.012)
2009 0.978 (0.935, 1.024)
2010 0.989 (0.945, 1.034)
2011 0.980 (0.934, 1.028)
2012 0.987 (0.942, 1.033)
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Table B.3: Relative risk estimates for a 1% increase in each covariate (not urban/rural covariate) and 95% credible
intervals for the covariates in a model with temporally varying regression parameters for respiratory disease. Significant
results are in bold
Covariate - Respiratory Median RR 95% CI
% 16-64 year olds claiming JSA
2003 1.100 (1.093, 1.078)
2004 1.101 (1.094, 1.110)
2005 1.104 (1.097, 1.113)
2006 1.101 (1.095, 1.109)
2007 1.101 (1.094, 1.109)
2008 1.108 (1.100, 1.116)
2009 1.108 (1.101, 1.116)
2010 1.104 (1.098, 1.113)
2011 1.104 (1.097, 1.112)
2012 1.106 (1.100, 1.114)
Log % Asian
2003 0.970 (0.953, 0.988)
2004 0.986 (0.969, 1.005)
2005 0.987 (0.971, 1.006)
2006 0.983 (0.966, 1.001)
2007 0.977 (0.960, 0.995)
2008 0.979 (0.961, 0.996)
2009 1.000 (0.982, 1.017)
2010 0.995 (0.978, 1.013)
2011 0.976 (0.960, 0.994)
2012 0.981 (0.963, 0.999)
Log % Black
2003 0.999 (0.990, 1.008)
2004 0.997 (0.988, 1.005)
2005 0.993 (0.985, 1.001)
2006 0.998 (0.990, 1.006)
2007 0.997 (0.989, 1.004)
2008 0.992 (0.984, 1.000)
2009 0.987 (0.979, 0.995)
2010 0.991 (0.983, 0.999)
2011 0.992 (0.984, 1.000)
2012 0.988 (0.980, 0.996)
Rural area
2003 0.993 (0.957, 1.040)
2004 1.011 (0.970, 1.055)
2005 1.015 (0.977, 1.058)
2006 1.027 (0.989, 1.072)
2007 0.991 (0.954, 1.030)
2008 0.968 (0.971, 1.051)
2009 0.978 (0.987, 1.069)
2010 0.989 (0.936, 1.010)
2011 0.980 (0.927, 1.000)
2012 0.987 (0.964, 1.041)
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Figure B.1: Boxplots of disease risk for a model without covariates for cerebrovascular disease, coronary heart
disease, and respiratory disease in IG’s in Scotland from 2003 - 2012. The IQR across IG’s are printed in red.
Outliers are those observations that lie outside 1.5*IQR.
this supplementary material shows the fitted values from the model with covariates
(x-axis) and the model without (y-axis) and the results are practically unchanged.
B.3 Multivariate spatio-temporal random effect
Figure B.3 shows the disease risk for each of the diseases in IG’s in Scotland across the
time period using the results from the model proposed by Quick et al. (2017b). When
compared to the same plot using the results from model 4.1 (Figure 4.9) it can be seen
that these results are practically identical. This is backed up in Figure B.4, which
shows the fitted values from our model (4.1) on the x-axis and the corresponding
fitted values from the model proposed by Quick et al. (2017b) (4.6) on the y-axis.
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Figure B.2: Scatterplot of fitted values from model with covariates vs fitted values from model without covariates.
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Figure B.3: Boxplots of disease risk from the Quick et al. (2017b) model for cerebrovascular disease, coronary heart
disease, and respiratory disease in IG’s in Scotland from 2003 - 2012. The IQR across IG’s are printed in red. Outliers
are those observations that lie outside 1.5*IQR.
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Figure B.4: Scatterplot of fitted values from our model (4.1) vs fitted values from the Quick et al. (2017b) model
4.6.
Again this shows that the results are very similar.
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